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Copper (Cu) plays key catalytic and regulatory roles in biochemical reactions 
essential for normal growth, development, and health. Defects in Cu metabolism 
cause Menkes and Wilson’s disease, myeloneuropathy, and cardiovascular disease 
and are associated with other pathophysiological states. Consequently, it is critical to 
understand the mechanisms by which organisms control the acquisition, distribution, 
and utilization of Cu. While it is well established that the enterocyte is a key 
regulatory point for Cu absorption into the body, how the intestine responds to 
systemic Cu requirements is poorly understood. Here, we demonstrate that fine-tuned 
Cu homeostasis is required for normal growth and development in C. elegans. 
Moreover, we show that CUA-1, the ATP7A/B homolog in worms, localizes to 
lysosome-like organelles (gut granules) in the intestine under Cu-overload conditions 
for Cu detoxification, while Cu-deficiency results in a redistribution of CUA-1 to 
basolateral membranes for Cu efflux to peripheral tissues. Defects in gut granule 
  
biogenesis exhibit result in abnormal Cu sequestration and increased susceptibility to 
toxic Cu levels. Our studies establish that CUA-1 is a key intestinal Cu exporter, and 
that its trafficking is regulated in response to systemic Cu status in worms. In 
addition, while the Cu transporter ATP7A plays a major role in both intestinal Cu 
mobilization to the periphery and prevention of Cu over-accumulation, it is unclear 
how regulation of ATP7A contributes to Cu homeostasis in response to systemic Cu 
fluctuation in mammals. Here we show, using Cu-deficient mouse models, that 
steady-state levels of ATP7A are lower in peripheral tissues (including the heart, 
spleen, and liver) under Cu deficiency and that subcutaneous administration of Cu to 
these animals restore normal ATP7A levels in these tissues. Importantly, ATP7A in 
the intestine is regulated in the opposite manner - low systemic Cu increases ATP7A 
while subcutaneous Cu administration decreases ATP7A suggesting that intestine-
specific non-autonomous regulation of ATP7A abundance may serve as a key 
homeostatic control for Cu export into the circulation. Altogether, our results 
implicate CUA-1/ATP7A Cu exporter in the intestine as a key modulator for 
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Chapter 1: Introduction 
 
Copper (Cu) has been harnessed throughout much of human civilization as a 
conductor of heat and electricity, as a building material and a constituent of various 
metal alloys, and as an antimicrobial agent over 10,000 years. However, the 
acquisition and metabolism of Cu and the diseases associated with Cu imbalance in 
human health have only recently been relatively studied. Cu is an indispensable trace 
element that is essential for a vast array of cellular processes in organisms from 
bacteria to humans. Cu serves as a redox-reactive, catalytic co-factor in the enzymatic 
reactions that drive oxidative phosphorylation, iron acquisition, protection from 
oxidative stress, neuropeptide maturation, blood clotting, and angiogenesis, among 
many other critical physiological functions (Table 1.1) (1-3). However, the ability of 
Cu to undergo reversible redox changes also makes this element deleterious to the 
organism when present in excess. Buildup of Cu in cells and tissues - particularly 
those that are highly oxygenated - can facilitate the production of reactive hydroxyl 
radicals leading to lipid peroxidation in membranes, oxidation of proteins, and 
structural damage to nucleic acids (4,5). Because of its dichotomous potential as an 
essential co-factor and toxic ions, cells have evolved sophisticated homeostatic 
mechanisms for the regulation of Cu acquisition and distribution (6,7). Organs 
communicate to ensure that intestinally derived micronutrients are distributed 
appropriately throughout the body, balancing cellular requirements against toxicity 
(8,9); all organismal Cu must pass through the intestine prior to distribution to other 






Table 1.1. List of selected Cu binding and Cu homeostasis proteins. Adopted and 




Protein involved in neuronal development and potentially 
Cu metabolism; cleavage leads to generation of Aβ Peptide 
that aggregates in senile plaque associated with 
Alzheimer’s disease. 
Atox1 Metallochaperone that delivers Cu to ATP7A and ATP7B 
Cu(I) transporters 
ATP7A  Cu(1)-transporting P-type ATPase expressed in all tissues 





Moorella thermoacetica bifunctional enzyme; reduces CO2 
to CO with subsequent 
CCS  Metallochaperone that delivers Cu to Cu/Zn SOD 
Ceruloplasmin (Cp) Serum ferroxidase that functions in Fe(III) loading onto 
transferrin 
Coagulation factors V 
and VIII 
Homologous pro-coagulants present on the surface of 
platelets, where they nucleate the assembly of multiprotein 
proteolytic complexes involved in blood coagulation 
COMMD1  Proteins involved in ATP7A/B trafficking 
CopZ Archaeoglobus fulgidus [2Fe-2S] and Zn(II)- containing Cu 
chaperone 
Cox17 Metallochaperone that transfers Cu to Sco1 and Cox11 for 
cytochrome oxidase Cu loading in mitochondria  
Ctr1 High-Affinity Cu(I) transporter involved in cellular Cu 
uptake 
Ctr2 Protein regulates biogenesis of a cleaved form of 
mammalian Ctr1 
Cu/Zn SOD (SOD1) Antioxidant enzyme, catalyzes the disproportionation of 
superoxide to hydrogen peroxide and dioxygen 
Cytochrome c oxidase 
(CCO) 
Terminal enzyme in the mitochondrial respiratory chain, 
catalyzes the reduction of dioxygen to water 
Dopamine β-
hydroxylase (DBH) 
Oxygenase, converts dopamine to norepinephrine 
Ethylene receptor 
(ETR1) 
Member of a plant receptor family that uses a Cu cofactor 






Hemocyanin  Oxygen transport protein found in the hemolymph of many 
invertebrates such as arthropods and molluscs 
Hephaestin Transmembrane multi-Cu ferroxidase; involved in iron 
efflux from enterocytes and macrophages 
Glucose oxidase  Pentose phosphate pathway oxidoreductase that catalyzes 
the oxidation of D-glucose into D-glucono-1, 5-lactone and 
hydrogen peroxide 
Laccase Phenol oxidase involved in melanin production 
Lysyl oxidase Catalyzes formation of aldehydes from lysine in collagen 
and elastin precursors for connective tissue maturation 





Catalyzes conversion of pptidylglycine substrates into α-
amidated products; neuropeptide maturation 
Prion protein (PrP) Protein whose fuction is unclear but binds Cu via the N-
terminal octapeptide repeats 
Steap 
proteins/Fre1/Fre2 
Family of metalloreductases involved in Fe(III) and Cu(II) 
reduction  
Tyrosinase Monophenol mono-oxygenase; melanin synthesis 
XIAP Inhibitor of apoptosis through binding and catalytic 
















among tissue types to ensure that Cu import and export from the intestine are 
coordinated with extra-intestinal tissue Cu requirements. Here, will review current 
knowledge of how Cu is imported, delivered, stored, and excreted at cellular levels 
and how Cu is acquired from the dietary sources and distributed to the peripheral 
tissues in mammals. 
 
Delivery of Cu into cells and subcellular compartments 
Cu import into cells 
Cellular Cu uptake into eukaryotic cells is accomplished via Ctr1, a high 
affinity Cu importer that is structurally and functionally conserved from yeast to 
humans (Figure 1.1) (10-12). The Ctr1 polypeptide is composed of three major 
domains: a methionine-rich N-terminus, a metal binding motif (MX3M) in the second 
transmembrane domain, and a cytoplasmic cysteine-histidine cluster in the C-
terminus. Structural and functional studies demonstrated that while the N-terminus 
motifs are thought to bind and facilitate Cu transfer to the channel, the metal binding 
motif on the second transmembrane domain is required for Cu uptake selectively via 
formation of Cu-S linkages (13,14). Genetic and structural studies indicate that Ctr1 
is present in the membrane as a homotrimer with a minimal membrane-spanning pore 
9 Å, which is likely where Cu ions traverse the membrane (14-16). Mammalian Ctr1-
mediated Cu uptake is specific for reduced Cu(I); however, the mechanism by which 
it is reduced prior to import is unknown (17). As candidates for this reducing activity, 






steap4), both of which are localized to the plasma membrane and intracellular 
membrane, are reported to possess cupric reductase activity in cultured cells (18-20). 
Further in vivo studies were needed to confirm this hypothesis. The essentiality of 
Ctr1 has been demonstrated by embryonic lethality in mice systemically deleted for 
Ctr1 (21,22).  
The regulation of Ctr1 activity is mainly controlled at the level of subcellular 
localization and abundance change. While the intracellular localization of Ctr1 is 
variable in different cells, it is predominantly localized to the plasma membrane in 
Cu-limiting conditions. However, its localization shifts to the intracellular vesicular 
membrane compartment as a result of Ctr1 endocytosis in response to increased Cu 
levels (23-25). Elevated exogenous Cu also induces degradation of glycosylated full-
lengths of Ctr1, presumably to prevent the excessive accumulation of toxic levels of 
Cu (25).  
While there is evidence for endosomal Cu stores in mammals, it has not been 
clearly established how stored Cu in vesicular compartments is mobilized to the 
cytoplasm. A protein structurally related to the mammalian Ctr1, called Ctr2, 
functions in the generation of a truncated form of Ctr1 lacking a large portion of the 
N-terminus histidine- and methionine-rich metal-binding ectodomain (26,27). While 
Ctr2 does not function as a direct Cu importer, it does stimulate the cleavage of the 
Ctr1 Cu-binding ectodomain, in a mechanism involving a direct, rate limiting reaction 
by the cathepsin L/B endolysosomal proteases (26,28). The truncated form of Ctr1 
(tCtr1) produced by the cleavage of the Ctr1 ectodomain has decreased cellular Cu 






Figure 1.1. A current model for Cu metabolism in mammalian cells.  A summary 
of the proteins involved in Cu acquisition, mobilization, stores, and export are shown 














































Interestingly, mouse embryonic fibroblasts (MEFs) lacking Ctr1 retain some 
Cu accumulation activity with low affinity for Cu(I), suggesting that alternative             
mechanism exist for Cu uptake. Cu-chloride complexes by an anion exchanger and 
divalent metal transporter 1 (DMT1) have been proposed as Cu entry pathways 
(29,30). However, accumulated evidence strongly suggests that intestinal DMT1 is 
not required for the intestinal transport of dietary Cu in mouse experiments, and 
genetic ablation will confirm the in vivo role of anion exchanger for Cu uptake (31).  
 
Cu chaperones and ligands in the cytoplasm 
Intracellular delivery of imported exogenous Cu ions to its target proteins and 
subcellular compartment requires fine-tuned control to sense cellular Cu levels, relay 
Cu ions, and prevent cytotoxicity from free intracellular Cu. Here, we will discuss the 
function and regulation of several Cu chaperones and other ligands including 
metallothionein (MT) and glutathione (GSH).  
Two cytosolic Cu chaperones, Cu chaperone for superoxide dismutase (CCS) 
and Atox1 deliver Cu to Cu, Zn superoxide dismutase (SOD1) and the ATP7A/B Cu 
exporter localized to the membrane of the secretory pathway, respectively (7). Both 
CCS and SOD1 are located in the cytoplasm, where active SOD1 functions as an 
antioxidant to protect cells from superoxide (O2-) radicals produced as a by-product of 
oxygen metabolism. While both proteins share similar protein structure, CCS does 
not have catalytic activity but instead delivers Cu to SOD1 by direct docking. CCS 
protein levels are post-translationally regulated in response to cellular bioavailable Cu. 






linked inhibitor of apoptosis (XIAP) E3 ubiquitin ligase or other E3 ligases and 
targeted for proteasomal degradation, resulting in low steady-state levels of CCS 
protein (32-35). While CCS levels do not influence SOD1 protein abundance, the 
enzymatic activity of SOD1 is dependent on both CCS and Cu levels (34,36). 
Deletion of CCS in mice is not lethal, but significantly lowers SOD1 activity, and 
reduces fertility in female mice (37). 
The Atox1 Cu chaperone transfers Cu to the metal binding sites in the 
cytosolic N-terminus of the Cu(I)-transporting ATPases, ATP7A and ATP7B. Loss of 
the gene encoding Atox1 in mice results in severe growth impairment (perinatal 
lethal) and reduced Cu transport across the placenta and systemic delivery (38). In 
addition, Atox1 has been suggested to act as a transcription factor, stimulating the 
expression of the genes encoding SOD3 and other proteins involved in cell 
proliferation under Cu overload conditions (39). 
MTs are small cysteine-rich proteins (~30% of amino acid residues) that bind 
up to 12 Cu(I) ions through their thiol group. MTs are capable of binding to some 
physiological metals, such as Cu, Zn, and Se, and thus their gene expression is 
dependent on availability of such dietary metals. How are MTs expression regulated 
in response to Cu levels? Under elevated Cu conditions, accumulated Cu in the 
nucleus induces the binding of metal transcription factor 1 (MTF1) to metal 
responsive elements (MREs) in the promoter of MT genes, resulting in rapid 
induction of MT gene transcription (40). Given that ablation of MT1 and MT2 in 
mice results in elevated susceptibility to toxic metals including Cu, MTs are required 





Cu storage under Cu deficiency. Consistent with this notion, MEFs lacking MT 
exhibited decreased cell viability under Cu-limiting conditions (43). 
GSH is a tripeptide (glutamate, cysteine, and glycine) that is capable of 
preventing damage to important cellular components caused by reactive oxygen 
species, and Cu is also one of the known binding ligands with lower affinity than MT. 
In Cu deficient rats, experimental removal of hepatic GSH levels lead to reduced Cu 
in the blood and bile but elevated hepatic Cu levels, suggesting that GSH may 
function in delivering Cu stores (44). In support of this, reduced GSH levels also 
inhibit ATP7A/B Cu exporters resulting in hyperaccumulation of Cu (45). It is 
possible that GSH may acts as a Cu chaperone in an Atox1-independent manner in 
loading Cu onto ATP7A/B. 
 
Cu delivery to mitochondria 
The oxidative phosphorylation system in mitochondria generates the huge 
amounts of cellular ATP used as energy currency. Five multi-subunit protein 
complexes (complexes I to V) in the mitochondrial inner membrane comprise the 
mitochondrial respiratory chain (46). Cytochrome c oxidase (CCO), termed complex 
IV, is the terminal enzyme of the oxidative phosphorylation and oxidizes cytochrome 
c and transfers electrons to molecular oxygen, Cox1 and Cox2 as a reaction of Cu–
electron-coupled transfer. Cox1 contains two heme moieties (a and a3) and the CuB 
site, the CuA site is positioned in the intermembrane space domain of Cox2 (47). 
During the assembly of CCO, Cu insertion into Cox1 and Cox2 is mediated by 





and COA6. COX17 is crucial for Cu delivery to both Cox1 and Cox2 from cytosol to 
IMS. The transfer of Cu ions from Cox17 to the CuB site in Cox1 is facilitated by 
Cox11 (48). In the case of Cu transfer from Cox17 to the CuA site in Cox2, two 
related essential mitochondrial proteins, Sco1 and Sco2, are involved. While Sco1 
solely participates in delivering Cu to Cox2, more importantly, COA6 is required for 
Sco2 for the relay of Cu to Cox2 (48,49). Mice lacking any of these genes involved in 
Cu transfer to CCO are known to show lethality in utero (7,49). While these proteins 
play a crucial role in the biogenesis of CCO and insertion of Cu into CuA and CuB 
sites, it is not known how Cu traverses mitochondria membranes. 
 
Cu delivery to secretory compartments and export out of cells 
Many Cu-dependent enzymes must receive Cu ions in the trans-Golgi network 
(TGN) for their structural integrity and enzymatic activity. The two mammalian P-
type Cu(I)-transporting ATPases, ATP7A and ATP7B, function in loading Cu onto 
newly synthesized Cu-dependent enzymes by delivering Cu into the lumen of the 
secretory compartment or exporting excess Cu from cells. Cellular Cu ions are 
transferred from Atox1 to six cysteine-rich cytoplasmic metal binding motif 
(GMTCXXC) repeats in the N-terminus of the ATP7A/B (50). Under basal 
conditions, the two efflux pumps are predominantly located in the TGN. However, 
under high Cu conditions, ATP7A is trafficked to vesicles and the plasma membrane 
to promote Cu export, whereas ATP7B to cytoplasmic vesicles. In polarized epithelial 
cells, both proteins show opposite direction in Cu-stimulated trafficking: ATP7A 





The di-leucine in the C-terminus and nine amino acids (37FAFDNVGYE45) in the N-
terminus are known to serve basolateral and apical membrane targeting signals in 
ATP7A and ATP7B, respectively (51-54). While both Cu pumps retain the similar 
conserved core structure and Cu transport function, these Cu exporters are not 
thought to have biologically redundant functions (7). Mutations in the gene encoding 
ATP7A are responsible for Menkes Disease, characterized by cerebral and cerebellar 
neurodegeneration, connective tissue disorders, coarse hair, and lethality typically by 
2 or 3 years. Physiologically, Menkes disease phenotypes are coupled to the inability 
to pump Cu across basolateral membrane of intestinal epithelial cells to the periphery, 
or across the blood brain barrier, resulting in hyperaccumulation of intestinal Cu and 
severe Cu deficiency in the periphery (50,55,56). Impaired ATP7B function in 
Wilson disease results in an excessive buildup of Cu in the liver and neurons (50,55).  
 
Cu homeostasis at the organismal level in mammals 
 Mammals have distinct anatomical and physiological tissues and organs, 
demanding different requirement for Cu ions; therefore, organ-specific and systemic 
Cu homeostasis is required to regulate toxic but essential Cu atoms. Here we briefly 








Figure 1.2. Current model for intestinal Cu absorption and peripheral 
distribution. The Ctr1 high-affinity Cu transporter is shown at the apical membrane 
of IECs. Cu is pumped into the secretory compartment for loading onto Cu-dependent 
enzymes, or out across the basolateral membrane by the Cu-transporting P-type 
ATPase ATP7A. In the bloodstream, Cu is transported via the portal vein to the liver. 
Hepatic Cu is transported to the peripheral tissues via the systemic circulation, and 






































Intestinal Cu uptake and export to portal circulation 
Dietary Cu(II) is reduced and subsequently taken up by Ctr1 localized on the 
apical membrane of intestinal epithelial cells (IECs) of the intestine (57). Imported 
Cu ions bind to Cu chaperones and ligands, as discussed above, and is routed for 
intracellular targets including mitochondria and SOD1, incorporated into Cu-
dependent proteins in the TGN, and mobilized across the basolateral membrane into 
peripheral circulation by ATP7A. Several factors such as sex, age, and the amount of 
dietary Cu are known to affect Cu uptake from dietary sources in the lumen of the 
intestine (7). Biotin labeling of Ctr1 in intact mouse intestine showed that Ctr1 is 
localized to both the apical membrane and intracellular vesicles of IECs under Cu 
adequate diet, whereas the majority of Ctr1 is found on the apical membrane in 
response to a Cu deficient diet, indicating that Ctr1 localization is regulated for 
optimal dietary Cu uptake (23). While no significant differences in ATP7A/B 
expressions were observed between pups and weaned rodents, suckling pups 
exhibited higher expression of Ctr1 at the apical membrane and elevated Cu levels in 
IECs than older mice, suggesting the age-specific differences in Cu demands (58).  
The critical importance of intestinal Ctr1 for dietary Cu uptake was proven by 
intestine-specific Ctr1 knockout mice, characterized by severe whole-body Cu 
deficiency, poor viability, and cardiac hypertrophy (15). However, some non-
bioavailable Cu was still accumulated in the IECs, suggesting that Ctr1-independnent 







Hepatic Cu uptake, storage, and export  
Once Cu is transferred to portal circulation from IECs, the liver takes up Cu 
via hepatic Ctr1 at the basolateral membrane of hepatocytes and distributes it to 
peripheral tissues. Also, as a major storage organ for Cu and other trace metals, the 
liver stores Cu and excretes excess Cu to the bile (58,59). While mice carrying a 
liver-specific ablation of Ctr1 displayed some reduced levels of hepatic Cu, activities 
of Cu-dependent proteins, and Cu excretion via the bile, no significant differences in 
Cu levels of the other peripheral tissues were observed, suggesting that a Ctr1-
independent mechanism that uptakes Cu and distributes it to circulation may exist 
(60). Like the age-dependent Ctr1 localization change in IECs, ATP7A abundances 
and Cu stores in the liver decline progressively during development from birth to 
adults (61). While it is not known if change of Cu levels in the liver is solely 
correlated with hepatic ATP7A expression, these data suggest that higher demands 
for Cu in peripheral tissues in young mice are supplied by hepatic Cu stores, 
presumably through ATP7A.  
Ceruloplasmin (Cp), Cu-dependent ferroxidase, is also known as the Cu 
deliverer to blood. Hepatic Cu is incorporated to apo-Cp by ATP7B and exocytosed 
to blood, and 70~95% of total circulating Cu is bound to Cp. However, deletion of the 
Cp gene in mice resulted in a normal range of Cu levels in blood and peripheral 
tissues, indicating that Cp may not crucial for exporting Cu to circulation (62,63). 
Hepatic ATP7B is responsible for metallation of Cu dependent enzymes in the TGN 





disease derived from ATP7B mutation can be explained by blockage of biliary Cu 
excretion (59,64). 
 
Cu metabolism in the heart  
Cardiac hypertrophy, a pathological enlargement of cardiomyocytes in the 
heart, is one of the major symptoms of Cu deficiency in mammals due to the 
requirement for Cu for CCO in mitochondrial oxidative phosphorylation and SOD1 
activity (65). Cardiac Ctr1 localizes to the intercalated discs in cardiomyocytes and 
supplies Cu for the constant contraction of myocytes (58). Cardiac-specific Ctr1 
knockout mice exhibited severe Cu depletion in the heart, cardiomyopathy, and 
perinatal lethality (61). Interestingly, ATP7A protein levels in both the liver and the 
intestine were drastically elevated in these knockout mice concomitant with decreased 
hepatic Cu levels and increased Cu in circulation. These data strongly suggest that 
inter-organ signaling of Cu status may exist to supply more Cu to Cu-demanding 
organs such as the heart from the major Cu storage and uptake organs (liver and 
intestine) by increasing expression of ATP7A Cu efflux pumps. 
 
Cu homeostasis in C. elegans 
Our understanding of the mechanisms that regulate Cu metabolism has been 
advanced through the use of several model organisms. Saccharomyces 
cerevisiae have been instrumental in uncovering the complex pathways orchestrating 





in the identification of mechanisms involved in metal-responsive transcription 
regulation (70-72). More recently, the optically transparent roundworm 
Caenorhabditis elegans (C. elegans) has emerged as a highly amenable model of 
micronutrient metabolism (73-75). Surprisingly, the C. elegans model system has 
been relatively unexploited for questions related to Cu homeostasis, despite the fact 
that these worms have a defined and highly versatile intestinal capacity for nutrient 
absorption (76-78). While C. elegans has been widely used in the study of the 
metabolism of metals including Fe, heme, and Zn (74,79-83), Cu-related studies have 
only been performed for chemosensation of Cu, Cu relay to SOD1, and checking 
tissue-wide expression of genes encoding the ortholog of Atox1 and ATP7A/B in 
worms (84,85).  
Previous studies have used yeast to demonstrate that cua-1 has a Cu efflux 
function, as the gene encoding worm CUA-1 was able to rescue a yeast strain lacking 
CCC2 gene, which encodes a functional counterpart (86). Worms harboring cua-1 
transcriptional reporters have been used to detect tissue-wide expression of cua-1, 
indicating that several tissues such as intestine and hypodermis express cua-1. An 
essential role of cua-1 for Cu transport in C. elegans has been suggested, as ablation 
of cua-1 results in embryonic lethality (85,87), however how CUA-1 in the intestine 
responds to systemic Cu status is not understood, and its intracellular location and Cu 
responsiveness also have not been determined. While worms also have orthologs of 
most proteins involved in Cu homeostasis in mammals, CCS was not found using a 
BLAST search. Interestingly, worms utilized Cu-GSH complexes to deliver Cu to 





Figure 1.3. Homologs of genes encoding proteins involved in Cu metabolism in 
C. elegans.  A summary of the proteins involved in Cu acquisition, mobilization, 
stores, and export in worms are shown in the figure. Proteins listed in black boxes are 
conserved worm proteins. “X” means there are no homologs, and “?” indicates that 








































Chapter 2: Materials and Methods 
 
Worm Methods 
Worm Culture and Strains 
C. elegans were cultivated at 20°C on nematode growth medium (NGM) 
plates seeded with Escherichia coli OP50 or HT115(DE3) as a food source. Strain 
information (including the Bristol N2 strain, transgenic strains, and deletion strains 
used in this study) is detailed in Supplemental Table. Several worm strains were 
obtained from the Caenorhabditis Genetics Center (CGC), which is funded by 
National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 
OD010440). Presence of the cua-1(ok904) allele was confirmed by sequencing of the 
cua-1 locus. Genotyping primers for the cua-1(ok904) allele can be found in 
Appendix II. Genotypes of transgenic animals and mutant worms were confirmed by 
DNA sequencing or PCR. CuCl2 was used as the source for Cu supplementation in 
NGM dishes and media in all experiments. 
 
Worm Analysis Using COPAS Biosort or Microscopy 
Gravid hermaphrodites were bleached to release their eggs, which were 
allowed to hatch and arrest at L1 stage in M9 buffer overnight. The resultant age-
synchronized L1 larvae were cultured on NGM plates for approximately 2.5 days. 
Worms from each condition (~200 worms) were analyzed for time of flight (length), 





Biometrica). To visualize live worms, animals were paralyzed in M9 buffer 
containing 10 mM sodium azide (NaN3) and mounted on agarose pads. GFP, 
mCherry, Cu probe CF4, autofluorescence, and LysoTracker fluorescence in worms 
were imaged using an SP5 X confocal microscope (Leica). 
 
Inductively-Coupled Plasma Mass Spectrometry (ICP-MS) 
Metal contents of worms and MEFs were measured using inductively coupled 
plasma mass spectrometry (ICP-MS) as previously described (15). Values were 
normalized to wet weight of worms or cells. For sample preparation, synchronized L1 
worms were grown on 10 cm NGM plates seeded with OP50 or HT115 RNAi 
bacteria and supplemented with the indicated amounts of Cu or BCS. Worm or cell 
pellets were collected and washed extensively with M9 buffer or PBS, respectively, 
transferred to acid-washed tubes, and frozen at -80°C. At least three independent 
biological replicates were analyzed. 
 
Reverse transcription quantitative PCR (RT-qPCR) 
Synchronized larvae were grown to the L4/young adult stage on NGM plates 
seeded with OP50 bacteria and supplemented with indicated concentrations of Cu or 
BCS. Then, the worms were extensively washed with M9 buffer and collected for 
RNA isolation. Briefly, worms were resuspended in TRIzol (Invitrogen) reagent 
followed by lysis using a FastPrep-24 (MP Biomedicals) homogenizer in Lysing 
Matrix Tubes (MP Biomedicals). Total RNA was isolated using TRIzol, treated with 





(Invitrogen). RT-qPCR was performed on an Agilent Mx3005P qPCR System 
thermocycler (Agilent Genomics) using SYBR Green JumpStart Taq ReadyMix 
(Sigma). Expression levels of cua-1 were compared to an internal GAPDH (gpd-2) 
control, and the fold changes were determined using the 2 (-ΔΔCt) method (90). The 
primers used for PCR are listed in Appendix II. 
 
Plasmid Construction and Transgenic Strain Generation 
To generate C. elegans expression plasmids, gene-specific gateway attB 
primers were used to amplify DNA sequences such as promoters, ORFs, and 3’ 
UTRs. Purified DNA fragments were recombined into donor vectors first, and then 
into expression plasmids using Gateway recombination reactions (Invitrogen). For 
mammalian cell expression plasmids, the GFP-tagged ORF of CUA-1 was digested 
with NheI and BamHI, and ligated into the pEGFP-C1 vector (Clontech). Transgenic 
animals were produced by introducing transcriptional or translational reporters into 
unc-119 worms using the PDS-1000 particle delivery system (Bio-Rad) for 
bombardment transformation (82,83). 
 
RNA Interference (RNAi) 
RNAi bacteria strains against cua-1 (Y76A2A.2) and pgp-2 (C34G6.4) were 
obtained from the Ahringer feeding library (91) and cuc-1 (ZK652.11) was obtained 
from the ORFeome-based RNAi library (92). Bacteria transformed with the empty 
L4440 vector were used as a negative RNAi control. Synchronized L1 animals were 





and 50 µg/mL carbenicillin) that were seeded with HT115(DE3) bacteria expressing 
dsRNA for each gene.  
 
Cell culture and Immunoblotting  
Atp7a+/+ and Atp7a−/− MEFs were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM; Lonza) supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum (FBS; Atlanta biologicals) and 100 units/ml penicillin/streptomycin (Lonza). 
The plasmid expressing CUA-1.1::GFP was transfected to Atp7a−/− MEFs using 
PolyJet (SignaGen). All cells were cultured under 5% CO2 at 37°C. Cells at ~70% 
confluence were collected and washed three times with ice-cold PBS (pH 7.4). Cell 
pellets were suspended in about 5 times their volume in ice-cold cell lysis buffer 
(PBS pH 7.4, 1% triton X-100, 0.1% sodium dodecyl sulfate, 1 mM EDTA) 
containing Halt protease inhibitor cocktail (Thermo Scientific), briefly vortexed, and 
incubated for 1 h. Early stage adult worms grown from synchronized larvae were 
collected and washed with M9 buffer. Worms were resuspended in the same lysis 
buffer followed by disruption using a FastPrep-24 (MP Biomedicals) homogenizer in 
the presence of glass beads. The same lysis buffer was used for disruption of MEFs 
on ice for 30 min. Cell suspensions and worm lysates were centrifuged at 16,000 × g 
at 4°C for 15 min. After centrifugation, the clarified lysates were used for 
immunoblotting, and protein concentrations were measured using the BCA Protein 
Assay Kit (Thermo Scientific). Samples (100 µg/lane) were fractionated on a 4-20% 
gradient gel (BioRad). The anti-ATP7A antibody (a gift from Dr. Stephen G. Kaler, 





a 1:1,000 dilution. The anti-CCS antibody (Santa Cruz Biotechnology) and anti-
GAPDH antibody (Sigma) were used at 1:4000 dilution and 1:10,000 dilution, 
respectively. Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG 
(Rockland Immunochemicals) was used as the secondary antibody for 
immunoblotting (1:5,000 dilution). Immunoblots were detected using SuperSignal 
West Pico Chemiluminescent Substrate reagents (Thermo Fisher Scientific) using a 
chemidocumentation imaging system (Bio-Rad). 
 
Staining with the Cu Probe CF4 and LysoTracker 
The Cu Fluor-4 (CF4) sensor combines a piperidine-substituted rhodol with a 
trifluoromethyl-substituted bottom ring bearing a thioether receptor, along with a 
matched control Cu Fluor-4 (Control CF4) dye that lacks the Cu-responsive receptor 
to help distinguish between Cu-dependent and dye-dependent responses (93,94). 
Replacement of the thioether-rich receptor arms for Cu(I)-recognition in CF4 by 
isostructural octyl groups in control CF4 provides a mimic of the size, shape, and 
hydrophobicity of thioethers but do not bind Cu, offering a matched pair of probes to 
disentangle Cu-dependent fluorescence responses from potential dye-dependent ones. 
We used the Rhodol based-CF4 probe and control CF4 probe (both final 
concentration, 25 µM) for staining Cu(I) in intact worms and 2 µM LysoTracker Red 
DND-99 (Invitrogen) for detecting gut granules. Both chemicals were prepared in M9 
buffer and dispensed onto NGM plates (74). L3 stage worms were cultured on these 
dishes for 12-16 h in the dark. Post-incubation, stained worms were transferred to 





After 2h incubation, worms were collected and washed three times with M9 buffer, 
and imaged via confocal microscopy. 
 
Cu-Microinjection Experiments 
To deliver Cu directly to the basolateral side of the intestine and peripheral 
tissues, CuCl2 solution was microinjected into the pseudocoelom in the posterior 
region of young adult worms that had been grown in 50 µM BCS treated NGM 
dishes. Histidine or CuCl2 with histidine (1:2 molar ratio) diluted in M9 buffer was 
injected to worms using an Eppendorf Femtojet microinjector attached to a Leica 
inverted microscope under specified settings (pi= 30 psi, pc=4.5 psi, ti= 4 sec). 
Worms were recovered on seeded plates for 6 h and then mounted on 2% agarose 
pads for imaging. 
   
Mammalian Methods 
Antibodies  
The anti-ATP7A antibody (generous gift from Drs. Stephen G. Kaler, 
National Institutes of Health (NIH), Bethesda, MD and Michael J. Petris, University 
of Missouri, Columbia, MO), anti-ATP7B antibody (generous gift from Dr. Svetlana 
Lutsenko, Johns Hopkins University, Baltimore, MD) anti-Ctr1 antibody (15), anti-β-
tubulin antibody (Cell Signaling Technology), anti-β-actin antibody (Sigma), anti-
COX-IV subunit IV antibody (Invitrogen), and anti-Na+/K+-ATPase (Thermo 





(Santa Cruz Biotechnology) and anti-GAPDH antibody (Sigma) were used at a 1:400 
dilution and 1:10,000 dilution, respectively. Horseradish peroxidase-conjugated anti-
rabbit or -mouse IgG (Rockland Immunochemicals) was used as the secondary 
antibody for immunoblotting at a 1:5,000 dilution. Immunoblots were detected using 
SuperSignal West Pico or Femto Chemiluminescent Substrate reagents (Thermo 
Fisher Scientific) using a chemidocumentation imaging system (Bio-Rad). The anti-
Na+/K+- ATPase antibody was purchased from the Developmental Studies Hybridoma 
Bank (DSHB) for immunofluorescence experiments. Alexa Fluor 488 anti-rabbit IgG, 
Alexa Fluor 568 anti-mouse IgG, Alexa Fluor 647 WGA-conjugate, and ProLong 
Gold Antifade mounting reagent with DAPI were obtained from Life Technologies. 
 
Cell Culture  
Rat intestinal epithelial cells (IEC-6) and HUVEC cells were obtained from 
the American Type Culture Collection (ATCC) and cultured according to the 
distributor’s recommendations. Wild-type (Ctr1+/+) and Ctr1−/− MEFs were cultured 
in Dulbecco’s Modified Eagle Medium (DMEM; Lonza) supplemented with 10% 
(v/v) heat-inactivated fetal bovine serum (FBS; Atlanta Biologicals), 1× MEM non-
essential amino acids (Lonza), 50 µg/mL uridine, 100 U/mL penicillin/streptomycin 
(Lonza), and 55 µM 2-mercaptoethanol. All cells were cultured under 5% CO2 at 
37°C. Cells at ~60% confluence were collected and washed three times with ice-cold 
PBS (pH 7.4). CuCl2 (Alfa Aesar) and bathocuproinedisulfonic acid Cu chelator 
(BCS; Acros) were used for Cu level-responsive ATP7A expression change 





experiments, IEC-6 cells were treated with 50 µg/mL cycloheximide (CHX; Sigma), 
20 µM MG-132 (Sigma), and 100 nM bortezomib (ApexBio). Cell pellets were 
suspended in ice-cold cell lysis buffer (PBS pH 7.4, 1% Triton X-100, 0.1% sodium 
dodecyl sulfate (SDS), 1 mM EDTA) containing Halt protease inhibitor cocktail 
(Thermo Scientific), briefly vortexed, and incubated for 1 h. Cell suspensions were 
centrifuged at 16,000 xg at 4°C for 15 min to remove insoluble material, and 
supernatants were collected. Protein concentrations were measured using the BCA 
Protein Assay Kit (Thermo Scientific). The indicated amount of protein extract was 
fractionated by SDS-gel electrophoresis on 4-20% gradient gels (Bio-Rad) and 
immunoblotted. 
 
IEC-6 cells were grown on 24-mm polyester membrane transwells with 0.4-
µm pores (Corning) until confluent.  When cultures reach to 90% confluence, the 
growth medium was exchanged every day. Formation of tight junctions was 
monitored by the measurement of transepithelial electrical resistance (TEER) using 
an EVOM2 meter and STX2 electrodes (World Precision Instruments). Cells were 
judged to be ready for Cu uptake experiments when the TEER value was ∼400 Ω× 
cm2. After incubating cells with 200 µM BCS for 24 h, both compartments were filled 
with fresh culture medium containing BCS, CuCl2, or 10 mM EDTA for 12 h. Cells 
were rinsed with ice-cold PBS (pH 7.4), scraped in the same lysis buffer to harvest, 






Primary hepatocytes were isolated from mice at P12 according to the 
procedure previously described in detail (95). Briefly, an incision was made on the 
right atrium with scissors to ensure a route for overflow, then perfusion was 
performed with calcium-free Hanks' balanced salt solution (HBSS; Lonza) 
supplemented with 0.5 mM EDTA (Sigma) at 37°C at a rate of 3.5 mL/min, followed 
by HBSS supplemented with 0.3 mg/mL collagenase (Sigma) and 5 mM CaCl2 under 
the same conditions at a rate of 5 mL/min. The total-collected liver cell suspension 
was then filtered through a 100-µm nylon mesh and centrifuged at 50 xg for 5 min. 
Next, the pellet was resuspended and incubated in DMEM with 10% FBS, 0.1 µM 
insulin (Sigma), and 100 U/mL penicillin/streptomycin. After 3 h of incubation at 
37°C in an atmosphere of 5% CO2, the medium was changed to M199 supplemented 
with 0.1 µM dexamethasone, 0.1 µM 3,3',5-triiodo-L-thyronine, 0.1 µM insulin, and 
100 U/mL penicillin/streptomycin and incubated for further analysis.  
 
Animal and Tissue Preparations  
For the Cu administration experiment, pups at P7 (C57BL/6J, Jackson 
Laboratory) were SQ administered 50 µL of saline containing 10 µg CuCl2 with 19.12 
µg L-histidine/g of mouse BW or 50 µL of saline alone for 3 consecutive days and 
sacrificed at P10. The intestinal Ctr1 knockout mice (Ctr1int/int) and control mice 
(Ctr1flox/flox and Ctr1flox/+) were generated as described previously (15). Ctr1flox/flox and 
Ctr1int/int mice pups were administered with same amount of Cu-histidine or saline 
alone given subcutaneously at P10 and dissected two days later (P12). To generate 





17, as previously described (58). Dams from wild type mice were fed Cu-deficient or 
Cu-adequate diets, consisting of a Cu-deficient purified diet (TD.80388, Envigo) and 
either sterilized distilled low-Cu drinking water or Cu-supplemented drinking water 
(20 µg CuCl2/mL), respectively. Pups were sacrificed at P15 due to clear evidence of 
severe Cu deficiency. All procedures involving animals were carried out in 
accordance with the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals and have been approved by the Institutional Animal Care and 
Use Committee at the University of Maryland, College Park (protocol number R-15-
14). Tissues were dissected following washing with ice-cold PBS, frozen in liquid 
nitrogen, and stored at −80°C until use. For the isolation of intestinal epithelial cells, 
the small intestine was opened along the long axis, washed in ice-cold PBS, and 
soaked in PBS containing 1.5 mM EDTA and protease inhibitors at 4°C for 30 min 
with gentle agitation (96). After incubation, the mesenchymal layer was removed, and 
intestinal epithelial cells were washed three times with ice-cold PBS with protease 
inhibitors and recovered by centrifugation at 2000 xg for 3 min. 
 
Dissected tissues or purified intestinal epithelial cells were homogenized in 
ice-cold cell lysis buffer (PBS pH 7.4, 1% Triton X-100, 0.1% SDS, 1 mM EDTA) 
containing Halt protease inhibitor cocktail (Thermo Scientific) in 1.5 mL centrifuge 
tubes by pellet mixer (VWR) on ice. Homogenates were incubated on ice for 1 h 
followed by centrifugation at 16,000 xg for 15 min at 4˚C. The supernatants were 
used as total extracts for immunoblotting. Protein concentrations were measured by 





standard and equal amounts of protein (100 µg/lane) were fractionated on a 4-20% 
gradient gel (Bio-Rad).  
 
Confocal Immunofluorescence Microscopy  
For the immunofluorescence analysis, intestines were washed with PBS and 
fixed in 4% (w/v) paraformaldehyde/PBS immediately following dissection. A 2 cm 
section of upper jejunum, positioned 1 cm from the stomach, was dissected and fixed 
with the same fixative solution overnight at 4°C with gentle shaking. Fixed tissue 
samples were processed and embedded into a paraffin block and sectioned at a 
thickness of 5 µm for immunofluorescence staining.  The deparaffinized sections 
were heated at a sub-boiling temperature in 1 mM EDTA buffer (pH 8.0) for 15 min 
to expose the antigen. Samples were blocked with 2% (w/v) BSA and 0.2% Triton X-
100 in PBS for 1 h and incubated with primary antibody (as described in the figure 
legends) for 1 h at room temperature. After washing with 0.2% BSA and 0.02% 
Triton X-100 in PBS, sections were incubated with Alexa Fluor 488 anti-rabbit IgG 
or Alexa Fluor 568 anti-mouse IgG (1:250 dilution in 1% (w/v) BSA in PBS) for 1 h 
at room temperature and washed with PBS. Then, the procedure of blocking and 
incubation with primary and secondary antibody was repeated as described above. 
Following incubation with Alexa Fluor 647 Conjugate of WGA for 1 h at room 
temperature followed by washing, sections were mounted with Gold antifade reagent 







Reverse transcription quantitative PCR (RT-qPCR)  
Total RNA was isolated from intestinal epithelial cells or liver tissues by 
TRIzol reagent (Ambion). After eliminating genomic DNA using DNA-free DNA 
Removal Kit (Ambion), first strand cDNA was synthesized using SuperScript VILO 
Master Mix (Invitrogen). RT-qPCR was performed on an Agilent Mx3005P QPCR 
System Thermocycler (Agilent Genomics) using SYBR Green qPCR Master Mixes 
(Applied Biosystems). Levels of Atp7a, Ctr1, Mt1, and Mt2 mRNA were compared to 
an internal Gapdh control in mouse tissues, and rat Atp7a transcript levels were 
compared to 18s rRNA control in IEC-6 cells, and the fold change was determined 
using the 2 (-ΔΔCt) method (90). The oligonucleotide primer sequences used for PCR 
can be found in Appendix III. 
 
Tissue Metal Measurements  
Cu and Fe concentrations were measured from nitric acid-digested cells or 
tissues by inductively coupled plasma mass spectrometry (ICP-MS) as described (97). 
Tissues were collected into acid-washed 1.5-mL microcentrifuge tubes and weighed, 
and the harvested cultured cells were washed with PBS three times and weighed. The 
values were normalized by wet weight (g) of cells or mouse tissues. More extensive 









Bioinformatics and Statistics 
Clustal Omega and ClustalW2 were used to generate a multiple sequence 
alignment and phylogenetic tree of a subset of cua-1 homologs (98). Transmembrane 
helices and Cu-binding motifs of CUA-1 homologs were predicted using TMHMM 
and the Conserved Domain Database (CDD) (99). Statistical significance was 
determined using a one-way or two-way ANOVA followed by Tukey’s post hoc test 
or two-tailed unpaired Student’s t-test in GraphPad Prism, Version 6 (GraphPad 
Software). All data are presented as mean ± SEM (standard error of the mean) or 
mean ± SD (standard deviation), and P-values less than 0.05 were considered to be 
statistically significant. 







Chapter 3: The Role of the Intestinal Cu Exporter CUA-1         
in Systemic Cu Homeostasis in Caenorhabditis elegans 
 
Summary 
Cu is essential for catalytic and regulatory functions in a wide range of 
biochemical reactions involved in mitochondrial respiration, connective tissue 
formation, and iron (Fe) metabolism (2,7). Cu deficiency is associated with 
pathologies that include anemia, neutropenia, and cardiomyopathy (2,100). 
Additionally, if its homeostasis is not properly regulated, Cu can be extremely toxic 
due to its stimulation of free radical production. Organisms finely tune Cu 
homeostasis through a combination of absorption, distribution, and efflux in multiple 
tissues. In many species, a key aspect of Cu homeostasis is facilitated by membrane-
bound Cu efflux pumps. Mammals have two primary Cu exporters which are 
structurally related: ATP7A and ATP7B P-type ATPases. In tissue-culture models, 
both proteins deliver Cu to the lumen of the secretory machinery for incorporation 
into various Cu-dependent enzymes at basal or low intracellular Cu concentrations. 
At elevated cellular Cu levels, ATP7A traffics to the plasma membrane to remove 
excess Cu from cells, and ATP7B relocates to the plasma membrane and endosomes 
to excrete Cu (7,50). In humans, mutations in the genes encoding ATP7A and ATP7B 
result in severe systemic Cu deficiency (Menkes disease) and hepatic/neuronal 





responsive steady-state distributions of ATP7A/B have been studied predominantly at 
the cellular level in tissue-culture models, and regulation of their trafficking by 
dietary Cu has not yet been thoroughly elucidated within an intact animal model 
(50,101,102). 
While the optically transparent roundworm C. elegans has emerged as a 
highly amenable model of micronutrient metabolism (73-75), the C. elegans model 
system has been relatively unexploited for questions related to Cu homeostasis, 
despite the fact that these worms have a defined and highly versatile intestinal 
capacity for nutrient absorption (76-78). To examine the effects of Cu deprivation and 
overload on the development of animals in vivo, we utilized C. elegans, which has 
been widely used in the study of the metabolism of metals including Fe, heme, and 
zinc (Zn) (74,79-83). While mammals have two Cu exporters, serving complementary 
functions in different tissues such as the gut and liver, lower metazoans (including 
nematodes [Caenorhabditis elegans] and insects [Drosophila melanogaster]) have 
only a single homolog of ATP7A/B (7,85,103). The protein product of C. elegans 
cua-1 shares very high sequence similarity with human ATP7A/B. Previous studies 
have used yeast to demonstrate that cua-1 has Cu efflux function, as the gene 
encoding C. elegans CUA-1 could rescue a yeast strain lacking CCC2 gene, which 
encodes a functional counterpart (86). In worms, transcriptional reporters have been 
used to detect cua-1 expression in several tissues, including the intestine. An essential 
role for cua-1 for Cu transport in C. elegans has been suggested, as deletion of cua-1 





to systemic Cu status is not understood, and its intracellular location and Cu 
responsiveness has not been determined.  
Here, we report the importance of Cu in C. elegans development and a distinct 
role for CUA-1 in mediating Cu transport. Expression of cua-1 specifically in the 
intestine is sufficient to rescue the embryonic lethal phenotype of the cua-1 mutant. A 
CUA-1 translational fusion protein primarily localizes to the basolateral membrane of 
the intestine under basal and Cu-deficient conditions, but redistributes to lysosome-
related organelles (gut granules) in response to elevated Cu levels in the diet. 
Moreover, Cu-injection into the pseudocoelom, a fluid-filled body cavity between the 
intestine and the body wall, leads to a significant endosomal re-localization of 
intestinal CUA-1 even in dietary Cu-deprived worms. Our studies show that intestinal 
CUA-1 is a key component regulating Cu supply and detoxification to maintain 
systemic Cu homeostasis in the intact animal. 
 
Results 
Dietary Cu levels affect worm growth  
Living organisms have an optimal range of Cu concentrations, and dietary 
excess or deficiency of Cu causes various diseases and developmental defects in a 
broad range of organisms (2,7,104). To determine the dietary Cu requirements of C. 
elegans grown on NGM plates fed with the Escherichia coli strain OP50, we 
followed worm growth over eight days under Cu restriction using the Cu(I)-specific 
chelator bathocuproinedisulfonic acid (BCS), or with Cu supplementation using 





Figure 3.1. Growth of C. elegans is affected by dietary Cu. (A) Population growth 
rates of wild-type N2 worms cultured in the presence of increasing amounts of CuCl2 
or BCS on NGM dishes. Fifty synchronized L1 stage worms were grown on 10 cm 
plates for eight days under specified conditions and quantified by microscopy. Error 
bars are mean ± SEM of three independent experiments. (B) Synchronized L1 worms 
were cultured on plates supplemented with different levels of Cu or BCS for three 
days. Representative DIC images of worms three days post-hatch are shown. Scale 
bar, 50 µm. (C) Synchronized L1 larvae grown on NGM plates for 2.5 days were 
sorted by a COPAS Biosort. Time of flight (TOF) and extinction (EXT) denote the 























Figure 3.2. Metal levels of C. elegans in response to dietary Cu. Total Cu (A), Fe 
(B), Zn (C) levels of L4 stage wild-type worms grown on agar plates with varying 
levels of dietary Cu were determined by ICP-MS. Error bars indicate mean ± SEM of 
3-6 independent experiments, and different letters indicate significantly different 



























 C. elegans displayed maximal growth in the low micromolar range of 
supplemental Cu and impaired growth at either end of the Cu spectrum, 100 µM BCS 
and 150 µM Cu, with smaller brood size and delayed development. Large amounts of 
Cu (≥ 200 µM) resulted in growth arrest at the L3 stage, likely due to Cu toxicity. 
Monitoring of animal development revealed that at optimal Cu (~2 µM), worms 
became gravid adults in 3 days, while most animals grown at high or low Cu 
conditions only reached the L3 to young adult stage at this time point (Fig. 3.1B).  
To quantify the effect of dietary Cu on each animal within a mixed 
population, we used a COPAS Biosort instrument. Animal development was 
significantly delayed by supplementation of high doses of either Cu or BCS (Fig. 
3.1C). To complement the analysis of how dietary Cu influences worm growth, whole 
animal Cu content was measured using inductively coupled plasma mass 
spectrometry (ICP-MS). Worms cultured with high Cu (150 µM) had only a 5-fold 
increase in Cu content as compared to animals grown on 10 µM Cu supplementation, 
whereas the relative ratio of supplemental Cu concentrations (15-folds) is higher, 
implying the existence of a homeostatic regulatory mechanism for maintaining 
optimal Cu levels in C. elegans (Fig. 3.2A). BCS treatment resulted in ~ 40% 
reduction in total Cu content as compared to no supplementation. No significant 
changes in Fe and Zn content were observed in worms treated with Cu or BCS (Fig. 
3.2B-C). Collectively, these data indicate that dietary Cu levels impact growth and 







CUA-1 is essential for larval development in C. elegans 
While vertebrates have two Cu exporters, unicellular organisms and 
invertebrates have a single Cu exporter, suggesting that the Cu exporter gene 
duplication to ATP7A and ATP7B occurred following the branching off of the 
vertebrate phyla (Fig. 3.3A-B). In worms, cua-1 encodes a putative Cu exporter (86), 
which shares about 45% sequence identity at the amino acid level with human 
ATP7A and ATP7B. Importantly, the motifs known to be essential for Cu transport 
and protein trafficking in the human ATP7A/B are highly conserved in CUA-1 (Fig. 
3.3B and Fig. 3.4B). The genomic structure of cua-1 consists of 16 exons, and it is 
predicted to encode two splice isoforms. The first isoform, cua-1.1 (Y76A2A.2a), 
contains all exons, whereas the cua-1.2 (Y76A2A.2b) isoform lacks the first two 
exons, which encode the first metal-binding domain (Fig. 3.4A-B).  
To ascertain the physiological function of cua-1, worms were analyzed for 
growth and developmental phenotypes after knockdown of cua-1. Without Cu 
supplementation, animals treated with cua-1 RNAi at the L1 stage became gravid 
adults in four days, but failed to lay eggs. For worms grown in the presence of 100 
µM BCS, treatment with cua-1 RNAi resulted in near total lethality, while vector 
control worms only showed a delayed F1 hatching (Fig. 3.5A). Together, these results 
indicate that cua-1 is required for normal growth in C. elegans. To further explore the 
importance of cua-1 in fecundity, total brood size was quantified. Regardless of 
RNAi conditions, addition of 100 µM BCS resulted in reduced brood sizes, indicating 






Figure 3.3. Phylogenetic analysis of CUA-1 orthologs. Phylogenetic analysis (A) 
and multiple sequence alignments (B) of CUA-1 orthologs in Caenorhabditis elegans 
(Ce), Arabidopsis thaliana (At), Saccharomyces cerevisiae (Sc), Drosophila 
melanogaster (Dm), Danio rerio (Dr), and Homo sapiens (Hs). Evolutionary 
distances (sequence changes) were used to infer the phylogenetic tree. (C) 
Sequencing results showing inserted and deleted molecular regions in the wild-type 























Figure 3.4. Gene structure and protein topology of cua-1. (A) Schematic diagram 
of the C. elegans cua-1 gene. The straight line indicates genomic DNA on C. elegans 
chromosome III. The cua-1.2 transcript lacks the first two exons as compared to the 
full-length cua-1.1 isoform. (B) Predicted CUA-1 membrane topology. Domains 
required for Cu transport activity, including metal- binding sites, a phosphatase 
domain, a CPC motif (Cys-Pro-Cys), a phosphorylation domain, an ATP- binding 
motif, and a dileucine-based sorting signal present in human ATP7A/B are highly 
conserved in CUA-1. The genomic regions of cua-1 that are deleted in the ok904 
allele are shown in the red box, and the N-terminal truncation in CUA-1.2 is shown in 

























Figure 3.5. cua-1 is required for larval development under low Cu conditions. 
(A) L1 worms were exposed to RNAi for 4 days with or without 100 µM BCS 
treatment; representative microscope images are shown. Note that cua-1 RNAi used 
in this study targets the last two exons of both cua-1.1 and cua-1.2. Arrowhead 
indicates eggs that have already been laid. (B) L4 larval stage worms grown under 
varying RNAi and BCS conditions were picked to individual plates, allowed to lay 
eggs, and transferred to fresh plates every 24 hours for three days. Eggs were counted 
for each brood treatment, and progeny number for each brood was determined as the 
sum of total eggs and larvae, n=5 (two-way ANOVA, Tukey’s post hoc test). Error 
bars represent average ± SEM. Values with different letters are significantly different 
from each other (P<0.05). (C) Wild-type P0 animals were precultured for three days 
on NGM plates containing 0 or 10 µM supplemental Cu, and synchronized F1 
progeny were cultured from the L1 stage for two days on plates with the indicated 
levels of BCS. TOF was determined by a COPAS Biosort. Lower values indicate 
more severely retarded growth of worms under dietary Cu deficient conditions as 
compared to controls (no BCS supplementation). Three independent experiments 
were performed with ~200 worms for each sample. Error bars represent average ± 
SEM, and different letters indicate significantly different means (P<0.05) (two-way 















In mammals, cytosolic Cu is delivered to either ATP7A or ATP7B by the Cu 
chaperone ATOX1. In C. elegans, cuc-1 is a putative ATOX1 homolog that has been 
previously identified by yeast complementation assay (85). Depletion of cua-1 or cuc-
1 by RNAi resulted in a decrease in brood size as compared to vector control RNAi 
(Fig. 3.5B). Double knockdown of cua-1/cuc-1 led to a severe egg-laying defect, 
suggesting that a CUC-1/CUA-1 Cu relay and transport pathway is conserved in C. 
elegans, analogous to the ATOX1-ATP7A/B pathway in mammals.  
To investigate the physiological significance of maternal Cu availability to 
progeny, RNAi against cua-1 with either 0 or 10 µM supplemental Cu was conducted 
for 3 days until parental animals (P0) reached adulthood, and their synchronized L1 
progeny (F1) were cultured under identical RNAi knockdown conditions in the 
presence or absence of BCS for 2.5 days. Worms treated with cua-1 RNAi whose 
parents were grown in 0 µM supplemental Cu displayed delayed growth rates in the 
presence of BCS as compared to those treated with vector control (data not shown). 
When mothers were provided with 10 µM supplemental Cu, the growth rate of F1 
progeny treated with control RNAi was faster than that of progeny from mothers that 
received no supplemental Cu (Fig. 3.5C). However, the growth rate of the cua-1 
knockdown progeny was not strongly affected when the mothers were cultured in 10 
µM supplemental Cu (Fig. 3.5C). These results suggest that viability of embryos is 








CUA-1 expression is regulated by dietary Cu 
To determine whether cua-1 is transcriptionally regulated by dietary Cu, wild-
type N2 worms were cultured with no supplementation, with 150 µM Cu, or with 100 
µM BCS, and mRNA levels were measured by reverse transcription quantitative PCR 
(RT-qPCR). Levels of cua-1 mRNA were modestly elevated under Cu-limited 
conditions compared to Cu supplementations (Fig. 3.6A). To further analyze cua-1 
expression and localization, we generated transgenic animals expressing CUA-
1::GFP translational fusions under the control of an endogenous promoter using the 
CUA-1.1 isoform, as this isoform is the full-length form of the CUA-1 gene. Pcua-
1::CUA-1.1::GFP transgenic animals showed similar tissue distribution patterns to 
the previously reported transcriptional reporter worms, which was primarily intestine, 
neurons, hypodermis, and pharynx (85), although the intestinal expression was 
concentrated mainly in the anterior of the intestine (Fig. 3.6B).  
The strain VC672 contains a deletion in cua-1(ok904), spanning exons 13 
through 15 (Fig. 2A; Supplemental Fig. S2C), which is genetically balanced due to 
the embryonic lethality of cua-1 mutant worms (87,105). The cua-1(ok904) deletion 
removes a region containing the last two transmembrane helices as well as an ATP-
binding motif and a dileucine-based sorting signal (Fig. 3.4A). The cua-1(ok904) 
mutant is rescued with the transgene Pcua-1::CUA-1.1::GFP, indicating that the CUA-
1.1::GFP translational fusion protein is functional (Fig. 3.7A). To further confirm 
whether the CUA-1.1::GFP translational fusion protein can transport Cu, we 
exploited previously established assays in Atp7a+/+ and Atp7a-/- mouse embryonic 





Figure 3.6. cua-1 is expressed in multiple tissues in C. elegans. (A) Wild-type L1 
worms were cultivated with no supplemental Cu, 150 µM Cu, or 100 µM BCS for 2.5 
days. The relative fold changes of cua-1 mRNA levels were determined by RT-qPCR. 
Bars indicate mean ± SEM of three independent experiments. Means followed by 
different letters are significantly different at p=0.05 (one-way ANOVA, Tukey’s post 
hoc test). (B) Live transgenic animals expressing a cua-1.1 translational reporter 
[Pcua-1::CUA- 1.1::GFP::unc-54 3’UTR] were imaged by confocal microscopy. I, 



































Figure 3.7. Cu deficiency induces cua-1 in C. elegans. (A) Elevated CUA-1.1::GFP 
expression in the hypodermis by BCS supplementation was detected in transgenic 
animals [Pcua-1::CUA-1.1::GFP::unc-54 3’UTR; cua-1(ok904)]. The arrowheads 
and dashed circles indicate the anterior intestinal cells and hypodermis, respectively. 
Note that b, c, e, and f are magnified images. Scale bars, 200 µm (a and d) and 25 µm 
(b, c, e, and f). (B-C) Immunoblot (B) and ICP-MS (C) analysis of Atp7a+/+ and 
Atp7a-/- MEFs transfected with either vector or CUA-1.1::GFP. Error bars represent 
mean ± SEM of three independent experiments. Means which share the same letters 
are not significantly different (P>0.05) (one-way ANOVA, Tukey’s post hoc test). 
(D) Normalized GFP was analyzed using a COPAS Biosort. Background 
fluorescence and neuronal CUA-1.1::GFP fluorescence (which is refractory to RNAi 
knockdown), are indicated by a’ and b’, respectively. As such, c’ represents CUA-
1.1::GFP expression specifically in the intestine, hypodermis, and pharynx. Error bars 
show mean ± SEM of a single experiment with ~200 worms. Groups that do not share 
the same letter are significantly different (P<0.05) (one-way ANOVA, Tukey’s post 
hoc test). (E) Immunoblot analysis of CUA-1.1::GFP in transgenic worms [Pcua-
1::CUA-1.1::GFP::unc-54 3’UTR; cua-1(ok904)]. Worm lysates were subjected to 
SDS-PAGE followed by immunoblotting using anti-GFP and anti-tubulin antibodies. 












Figure 3.8. Loss of cua-1 specifically in the intestine causes embryonic lethality. 
Depletion of cua-1 in the intestine recapitulated the reduced fecundity of whole-
animal RNAi. Wild-type N2, RNAi resistant worm strain (rde-1), and tissue-specific 
RNAi lines were cultured on RNAi dishes with indicated concentration of Cu or BCS. 
Int, intestine-specific RNAi; Mus, muscle-specific RNAi; Hyp, hypodermis-specific 
RNAi; Error bars represent mean ± SEM. Values with one different letter superscript 
are significantly different from each other (P<0.05). n=3 (two-way ANOVA, Tukey’s 







































showed increased expression of Cu chaperone for superoxide dismutase (CCS), 
indicating decreased levels of cellular Cu (33,34) as compared to Atp7a-/- MEFs 
transfected with an empty vector (Fig. 3.7B). Over-accumulated Cu in Atp7a-/- MEFs 
was rescued by ectopic expression of CUA-1.1::GFP (Fig. 3.7C), further indicating 
that CUA-1.1 can export Cu. Moreover, these results demonstrate that a C-terminal 
GFP tag does not significantly interfere with CUA-1 function.  
Unexpectedly, when transgenic worms (Pcua-1::CUA-1.1::GFP) were 
maintained at low Cu concentrations (50 µM BCS), stronger CUA-1.1::GFP 
expression was observed in the hypodermis, while GFP expression levels were not 
altered in other tissues such as the intestine and neurons (Fig. 3.7A). Indeed, 
quantification of CUA-1.1::GFP by COPAS Biosort and immunoblotting assay 
showed significantly enhanced CUA-1.1::GFP levels under low Cu conditions, 
suggesting that Cu-dependent regulation in the hypodermal cells contributes to the 
overall steady state abundance of CUA-1.1. (Fig. 3.7D-E).  
To determine the contribution of each tissue to the embryonic lethal 
phenotype of cua-1 mutant worms, we carried out tissue-specific RNAi experiments. 
Mutant rde-1 worms are resistant to RNAi, but restoring tissue-specific expression of 
the wild-type rde-1 cDNA in these mutants confers RNAi sensitivity to a specific 
tissue (107). We depleted cua-1 in wild-type N2, WM27 (rde-1 mutant, RNAi 
insensitive), VP303 (Pnhx-2::RDE-1, intestine only RNAi), WM118 (Pmyo-3::RDE-1, 
muscle only RNAi), and NR222 (Plin-26::RDE-1, hypodermis only RNAi) worm 
strains (82). Knockdown of cua-1 in the intestine resulted in reduced fecundity 





crucial for the survival of worms. While significant effects were not observed when 
cua-1 was knocked down in muscle, depletion of cua-1 in the hypodermis caused a 
severe reduction in brood size under low dietary Cu conditions (Fig. 3.8). Cu 
supplementation (10 µM) was able to rescue the brood sizes phenotype caused by 
cua-1 RNAi in each of these strains (Fig. 3.8). These results imply a critical role of 
both intestinal and hypodermal CUA-1 in worm growth under Cu-deficient 
conditions. 
 
Intestinal expression of cua-1.1 is sufficient to rescue the lethal phenotype of cua-
1(ok904) 
Given that targeted depletion of cua-1 in the intestine caused similar 
phenotypes as whole-body RNAi, we examined the subcellular localization of CUA-
1.1 by driving the expression of CUA-1.1::GFP from the strong constitutive intestine-
specific vha-6 promoter (108). Pvha-6::CUA-1.1::GFP localized to basolateral 
membranes and to intracellular compartments, reminiscent of basolateral sorting and 
recycling endosomes in the C. elegans intestine (Fig. 3.9A) (109). Importantly, the 
embryonic lethal phenotype of the cua-1 (ok904) mutant can be rescued by intestine-
specific expression of CUA-1.1::GFP (Fig. 3.9B-C) suggesting that the intestine is the 
key site of Cu regulation in C. elegans. These results are further corroborated by the 
fact that RNAi depletion of either cuc-1 or cua-1 in Pvha-6::CUA-1.1::GFP; cua-
1(ok904) transgenic animals grown in low Cu results in a lethal phenotype that can be 
rescued by Cu supplementation. These observations suggest that a CUC-1/CUA-1 Cu 





dietary Cu restriction (Fig. 3.9B-C). To further assess the significance of intestinal 
CUA-1 function under varying Cu availability, F1 progeny of N2 wild-type, Pvha-
6::CUA-1.1::GFP, and Pvha-6::CUA-1.1::GFP; cua-1(ok904) worms derived from P0 
worms exposed to 10 µM Cu were grown to the L4/young adult stage under different 
dietary Cu conditions and then analyzed by COPAS Biosort. Transgenic animals 
expressing CUA-1.1::GFP under control of the vha-6 promoter exhibited a reduced 
growth phenotype when exposed to high Cu, and enhanced growth under Cu 
restriction in a dose-dependent manner (Fig. 3.9C and 3.10A). We attribute the Cu 
hypersensitivity to the constitutive overexpression of CUA-1.1 in the intestine, which 
would lead to export Cu into the worm body. In line with the assertion that intestinal 
CUA-1 is crucial for Cu delivery to extraintestinal tissues, depletion of cua-1 by 
RNAi in both wild-type and Pvha-6::CUA-1.1::GFP; cua-1(ok904) worms resulted in 
improved growth under toxic Cu conditions and growth inhibition under Cu 
restriction as compared to vector RNAi (Fig. 3.9C and 3.10A-B). To further 
understand the role of cua-1 in Cu metabolism, we measured total worm Cu content 
using ICP-MS. In the presence of 50 µM Cu, either cua-1 or cuc-1 RNAi knockdown 
in wild-type worms resulted in approximately 30% lower total Cu content than in 
control worms, whereas worms without Cu supplementation exhibited similar total 
Cu contents under both RNAi conditions (Fig. 3.10C). These results suggest that 








Figure 3.9. CUA-1 localizes to the basolateral membrane of the intestine and is 
crucial for survival in Cu-deficient condition. (A) Transgenic worms expressing a 
cua-1.1 translational reporter [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR] were imaged 
by confocal microscopy. The bright field image (a) shows the morphology of the 
worm intestine, and the green signal (b) shows CUA-1.1::GFP expression therein. 
Dotted lines indicate apical membrane, solid lines indicate basal membrane, and 
arrowheads indicate lateral membranes in polarized intestinal cells. Scale bar, 20 µm. 
(B-C) Survival rates (B) and images (C) of transgenic worms [Pvha-6::CUA-
1.1::GFP::unc-54 3’UTR; cua-1(ok904)] cultured on RNAi plates supplemented with 
either Cu or BCS 48 h post-hatch. Error bars indicate average ± SEM. Means that do 
not share a letter are significantly different (P<0.05). n=3 (two- way ANOVA, 























Figure 3.10. Cu export by intestinal CUA-1 is essential for survival. (A) P0 
worms were treated with 10 µM supplemental Cu on NGM plates with E. coli OP50. 
Synchronized L1 stage wild-type N2 worms and transgenic worms ([Pvha-6::CUA-
1.1::GFP::unc-54 3’UTR] and [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR; cua-
1(ok904)]) were grown for 2-2.5 days on NGM plates and analyzed using a COPAS 
Biosort. Error bars indicate mean ± SEM of ~200 worms (*P < 0.05, **P < 0.01, and 
***P < 0.001) (two-way ANOVA, Tukey’s post hoc test). (B) Synchronized L1 stage 
wild-type N2 worms and transgenic worms [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR; 
cua-1(ok904)] were fed control or cua-1 RNAi bacteria and analyzed using a COPAS 
Biosort. TOF equivalent to zero indicates lethal phenotype. Error bars represent mean 
± SEM of ~200 worms (***P < 0.001) (two-way ANOVA, Tukey’s post hoc test). 
(C) Total Cu levels of L4/young adult stage wild-type worms grown on NGM plates 
with 0 or 50 µM supplemental Cu as determined by ICP-MS. Error bars indicate 
mean ± SEM of six independent experiments. Means that do not share letters are 






















Intestinal CUA-1.1 distribution is regulated by Cu levels 
Cu-responsive fluorescent probes have been used to visualize the distribution 
of Cu in a variety of model systems (93,110-112). After conducting several pilot 
studies with a number of different Cu probes in C. elegans, we selected the newly 
developed Cu(I) probe CF4 based on its high specificity (see Materials and Methods 
for details). To investigate the dynamics of Cu levels in the intestine, we pre-exposed 
worms expressing CUA-1.1::GFP in the intestine to either 50 µM CuCl2 or 50 µM 
BCS followed by incubation with CF4. We observed that worms exposed to 
supplemental Cu accumulated more fluorescence puncta in the intestine than worms 
treated with BCS, while a control CF4 probe, which lacks the Cu-binding atoms but 
retains the same lipophilic dye platform, displayed weaker staining (Fig. 3.11). These 
results indicate that CF4 detects labile Cu levels in vesicles of the intestine in C. 
elegans. 
To test if dietary Cu alters CUA-1.1 localization, transgenic animals harboring 
a cua-1.1 translational reporter driven by the vha-6 promoter were grown under 
varying Cu concentrations and then imaged using confocal microscopy. In the 
presence of 50 µM BCS (Fig. 3.12 and 3.13A) or no supplemental Cu (data not 
shown), intestinal CUA-1.1::GFP localized predominantly to basolateral membranes 
(Fig. 3.12, a and f), as well as low levels being detectable in intracellular 
compartments. We identified these compartments as Golgi, as some of them 
overlapped with the Golgi marker MANS::mCherry (Fig. 3.13A). Strikingly, in the 
presence of 25 µM supplemental Cu, CUA-1.1::GFP was redistributed to a cellular 





1.1::GFP containing vesicles overlapped with the autofluorescence of gut granules 
(Fig. 3.12, j), an intestine-specific lysosome-related organelle, indicating that Cu may 
be concentrated at these sites (113,114). 
To examine the relationship between CUA-1.1 and Cu, transgenic animals 
expressing CUA-1.1::GFP were cultured with the Cu probe CF4. In worms cultured 
with 25 µM Cu, CF4 and CUA-1.1::GFP fluorescence overlapped almost completely, 
suggesting that CUA-1.1 localizes to the gut granules that concentrate Cu in response 
to toxic levels of environmental Cu (Fig. 3.12, k). Additionally, intestinal CUA-
1.1::GFP localization shifted from punctate staining to larger vesicles as worms were 
exposed to increasing concentrations of dietary Cu (Fig. 3.13B). CUA-1.1::GFP 
expression in the intestine driven by the endogenous cua-1 promoter rather than the 
vha-6 promoter also showed similar trafficking in response to changes in dietary Cu 
(Fig. 3.13C). Worms in which cua-1 had been depleted by RNAi showed 
dramatically decreased levels of CF4 fluorescence in the intestine as compared to 
control worms (Fig. 3.12, i and u) suggesting that CUA-1.1 acts to export Cu to gut 
granules. In summary, CUA-1.1 mainly resides on the basolateral membranes under 
basal and Cu-deficient conditions, but localizes to gut granules in response to 
increasing dietary Cu. Note that these changes are not due to Cu-responsive elevation 
in protein abundance of intestinal CUA-1.1 (Pvha-6::CUA-1.1::GFP) in transgenic 
worms, as immunoblotting and COPAS Biosort analysis showed no significant 







Figure 3.11. Cu accumulation in worms is monitored by CF4 Cu probe. 
Fluorescence images of control-CF4 or CF4 Cu probe staining in transgenic animals 
[Pvha-6::CUA-1.1::GFP::unc-54 3’UTR] cultured with 50 µM supplemental Cu or 









































Figure 3.12. Localization of intestinal CUA-1.1 is altered by Cu levels. Confocal 
images of transgenic animals [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR] expressing 
CUA-1.1::GFP in the intestine cultured with the Cu probe CF4 or the control CF4 
probe, the indicated levels of supplemental Cu or BCS, and control or cua-1 RNAi. 
Images show intestinal cells, and arrowheads indicate representative gut granules and 







































Figure 3.13. Subcellular localization of intestinal CUA-1.1 is changed by Cu 
supplementation. (A) Confocal images of transgenic animals expressing both CUA-
1.1::GFP and MANS::mCherry (a Golgi-localized mannosidase-mCherry fusion 
protein) in the intestine. Arrowheads indicate colocalization of CUA-1.1::GFP with 
MANS::mCherry, and insets are magnified images of boxed regions. Scale bar, 20 
µm. (B) Confocal images were taken of transgenic animals [Pvha-6::CUA-
1.1::GFP::unc-54 3’UTR] under varying Cu conditions. Arrowheads indicate 
representative CUA-1.1::GFP puncta. Scale bar, 10 µm. (C) Confocal images of the 
intestinal cells (arrowheads) of transgenic worms [Pcua- 1::CUA-1.1::GFP::unc-54 
3’UTR; cua-1(ok904)] grown with Cu or BCS supplementation. Scale bar, 20 µm. 
(D-E) Intestinal CUA-1.1::GFP expression levels were determined by 
immunoblotting (D) and a COPAS Biosort (E). Tubulin is shown as a loading control. 
Note that a’ represents background fluorescence and b’ represents CUA-1.1::GFP 
expression in the intestine. Error bars indicate mean ± SEM of a single experiment 
with ~200 worms. Means followed by different letters are significantly different at 













Figure 3.14. Localization of CUA-1.1 in hypodermis is not affected by Cu levels. 
Lateral view of transgenic animals [Pdpy-7::CUA-1.1::GFP::unc-54 3’UTR] 
expressing CUA-1.1::GFP in the hypodermis. Seam cells are mostly embedded in the 
hyp7 syncytium. Note that images in the first and second columns are from 































We next expressed CUA-1.1::GFP in the specialized epithelial cells of the C. 
elegans hypodermis using the hypodermis-specific dpy-7 promoter (113). Confocal 
microscopy studies in transgenic worms expressing Pdpy-7::CUA-1.1::GFP showed 
that in hypodermal tissues, plasma membrane localization of CUA-1.1::GFP was not 
affected by dietary Cu, suggesting that Cu-responsive trafficking of CUA-1.1 protein 
is intestine-specific (Fig. 3.14).  
To further explore if the intracellular localization of intestinal CUA-1.1::GFP 
is altered by elevated Cu status in the pseudocoelom, approximately 100 µg CuCl2 per 
g of worm (wet weight) in M9 buffer was injected into the pseudocoelom of adult 
worms harboring the CUA-1.1::GFP transgene, which had been preincubated with 50 
µM BCS. Interestingly, we observed a punctate pattern of CUA-1.1::GFP in the 
intestine of animals injected with Cu, while M9-injected controls showed 
predominately basolateral membrane localization (Appendix IV), implying the 
existence of a systemic Cu homeostasis mediated by the trafficking of intestinal 
CUA-1.1. 
 
CUA-1.1 is required for Cu detoxification in the intestine 
To further investigate the dynamics of CUA-1.1 localization in response to 
sub-toxic doses of Cu supplementation, we assayed CUA-1.1 colocalization with 
LysoTracker, a lysosome-specific fluorescent dye (114,115). In the presence of 50 
µM Cu, LysoTracker was observed in intestinal vesicles surrounded by membrane-
bound CUA-1.1::GFP (Fig. 3.15A). Upon RNAi knockdown of cua-1, the number 





RNAi knockdown pgp-2, which encodes an ABC transporter that is required for gut 
granule biogenesis and localizes to the gut granule membrane (114,116), significantly 
reduced LysoTracker staining and prevented CUA-1.1::GFP-containing vesicle 
formation, while CUA-1.1::GFP was detected on the basolateral membrane (Fig. 
3.15A). These results further suggest that CUA-1.1 localizes to the membranes of gut 
granules and gut granules are the destination of Cu sequestered by CUA-1.1 in the 
intestine when animals are exposed to high dietary Cu.  
To determine whether Cu sequestration into gut granules by CUA-1.1 
contributes to Cu detoxification, we tested Cu sensitivity by measuring the growth 
rate of C. elegans in the presence of increasing concentrations of Cu. When compared 
to control worms, pgp-2 depleted worms showed increased sensitivity to high Cu, as 
they displayed a dose-dependent decrease in growth rate in response to Cu (Fig. 
3.15B). To quantify Cu sequestration defects in gut granule-deficient worms, we 
measured total Cu content in worms by ICP-MS. pgp-2 mutant worms cultured in 50 
µM Cu displayed reduced total Cu content as compared to wild-type worms (Fig. 
3.15C). Consistent with previous reports, pgp-2 mutant worms displayed lower Zn 
content independent of Cu supplementation (Fig. 3.15D-E) (74). These results 
indicate that Cu deposition accounts for a significant proportion of total body Cu in 









Figure 3.15. CUA-1.1 sequesters excess Cu to gut granules. (A) Confocal images 
of transgenic animals [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR] exposed to varying 
RNAi conditions in the presence of 50 µM supplemental Cu, followed by incubation 
with LysoTracker. Boxed images in the top row are enlarged at the corner of each 
panel. Scale bar, 10 µm. (B) Synchronized wild-type L1 larvae were cultured on 
RNAi plates supplemented with the indicated concentrations of Cu for 2.5 days. TOF 
was determined using a COPAS Biosort. Error bars indicate average ± SEM of two 
independent experiments. (**P < 0.01) (two- way ANOVA, Tukey’s post hoc test). 
(C-E) ICP-MS was used to measure total Cu (C), Fe (D), and Zn (E) levels in wild-
type and pgp-2(kx48) worms grown in the presence of 0 or 50 µM supplemental Cu. 
Error bars indicate mean ± SEM of three independent experiments. Values with one 
different letter are significantly different from each other (P<0.05) (two-way 
































CUA-1 isoforms function coordinately to maintain systemic Cu levels 
RNAseq assays with synchronized populations of worms treated with 
different Cu or BCS levels revealed the existence of cua-1.2 variant as annotated 
(Fig. 3.4A), though relative levels of the two isoforms have not been established 
(unpublished work). To examine whether intestinal CUA-1.2 also retains the capacity 
to traffic in response to a high Cu diet, we generated transgenic worms expressing a 
CUA-1.2::GFP translational fusion driven from the intestinal vha-6 promoter. 
Confocal microscopy analysis showed that CUA-1.2::GFP is localized to the 
basolateral membranes irrespective of dietary Cu concentration (Fig. 3.16A). 
Additionally, CUA-1.2::GFP did not colocalize with autofluorescent gut granules 
under high Cu conditions suggesting CUA-1.2 functions constantly at basolateral 
membranes. Since CUA-1.1 has additional 122 amino acid sequences at the N-
terminus end compared to CUA-1.2, it is plausible that Cu-dependent trafficking of 














Figure 3.16. Cu homeostasis in worms is maintained by distinctly localized 
intestinal CUA-1 isoforms. (A) Confocal images of transgenic animals [Pvha-
6::CUA-1.2::GFP::unc-54 3’UTR] expressing CUA-1.2::GFP in the intestine in the 
presence of 50 µM of supplemental Cu or BCS. Scale bar, 10 µm. (B) A model of Cu 
homeostasis in C. elegans is shown. Dietary Cu ions are transported from the lumen 
of the intestine to the enterocytes by an unidentified Cu importer, and CUC-1 delivers 
Cu to CUA-1. Under basal Cu or Cu-deficient conditions, CUA-1.1 isoform localizes 
to the basolateral membrane and Golgi to either export Cu ions to peripheral tissues, 
or to direct Cu into the secretory pathway. CUA-1.2 consistently localizes to the 
basolateral membrane of enterocytes regardless of Cu conditions. CUA-1.1 is 
redistributed to the gut-granule membranes in response to elevated Cu levels in order 
























Dietary Cu availability can fluctuate widely depending upon an organism’s 
immediate environment, as would be the case in C. elegans that lives in soil. In the 
current study, we show that CUA-1.1 is expressed in intestinal cells and normally 
localizes to the basolateral membrane and intracellular compartments, such as the 
Golgi. When worms are exposed to higher Cu levels, redistribution of intestinal 
CUA-1.1 promotes Cu sequestration into lysosome-related organelles called gut 
granules. Defects in gut granule biogenesis lead to decreased Cu accumulation and 
increased susceptibility to toxic Cu levels. Together, these results suggest that Cu 
homeostasis is regulated by altering the localization of intestinal CUA-1.1 to either 
the basolateral membrane for delivery of Cu to peripheral tissues, or to the gut 
granule membrane to prevent Cu toxicity (Fig. 3.16B). 
In C. elegans, which lack a liver, the intestine has been thought to perform 
functions associated with both the intestine and the liver (117). Worms encode only 
one Cu exporter gene, cua-1, raising the question as to whether CUA-1 accomplishes 
some or all of the similar functions as ATP7A/B in the intestine and liver of 
mammals (86). We found that CUA-1 protein abundance in the intestine was not 
changed by dietary Cu. Instead, both CUA-1 isoforms localize to basolateral 
membranes and intracellular compartments including the Golgi under basal and Cu-
limiting conditions. The CUA-1.1 isoform alone redistributes to the gut granules 
when worms are exposed to high levels of Cu, indicating that CUA-1 shares 
physiological features of mammalian ATP7A and ATP7B. Enrichment of CUA-1.1 to 





suggests a distinct role for intestinal CUA-1.1 in detoxification of excess Cu in C. 
elegans. Although relocation of CUA-1.1 and ATP7B to the gut granules and apical 
membrane, respectively, in polarized cells is not identical, the direction of trafficking 
towards preventing systemic Cu toxicity is similar. Taken together, these data 
indicate that intestinal CUA-1 functions as Cu exporters in worms like ATP7A/B in 
both the intestine and liver of mammals in order to maintain Cu balance in the body.  
Given that CUA-1.2 lacks a portion of the N-terminal intracellular domain of 
CUA-1.1 and is targeted constitutively to the basolateral membrane even under Cu-
loaded conditions, necessary trafficking information may exist in the first 122 amino 
acids of CUA-1.1 for Cu responsiveness and correct targeting to gut granules. Several 
intriguing questions arise from this observation. What route does CUA-1.1 take to 
reach gut granules when intracellular Cu is increased? Where within the first 122 
amino acids is the crucial targeting signal? What cellular machinery recognizes the 
Cu signal? One possible sorting complex is the Biogenesis of Lysosome-related 
Organelles Complex-1 (BLOC-1), which is a known regulator of intracellular 
trafficking to lysosome-related organelles in mammals, Drosophila, and C. elegans 
(118-120). ATP7A is known to supply Cu to melanosomes in a BLOC-1-dependent 
manner in mammalian cells, and BLOC-1 subunits are also required for the proper 
trafficking of gut granule cargo in worms (118,121). Given that CUA-1.1 localizes to 
gut granules, and that ATP7A localizes to melanosomes in response to elevated levels 
of Cu, redistribution of the Cu exporter may require the BLOC-1 complex and related 





We have determined that gut granules function to sequester excess Cu via 
CUA-1.1 in the intestine. Ablation of cua-1 by RNAi does not interfere with the 
formation of gut granules, but Cu was not readily detected by a Cu probe in gut 
granules upon the loss of CUA-1.1. RNAi depletion of pgp-2 genes resulted in 
significantly reduced numbers of gut granules and increased sensitivity to Cu toxicity. 
However, whether stored Cu is capable of being reutilized under Cu-limiting 
conditions was not determined. Studies by the Kornfeld group have shown that gut 
granules act to detoxify and store dietary Zn via the CDF-2 Zn exporter (74). When 
worms were exposed to high concentrations of dietary Zn, gut granules displayed a 
bilobed morphology, which was not observed in our studies with CUA-1.1 and high 
dietary Cu. We speculate that gut granules may function as a central site of metal 
storage to prevent its cytotoxicity. This is specifically relevant since depletion of the 
metallothionein genes mtl-1 and mtl-2 by RNAi does not result in the expected 
enhanced susceptibility to Cu toxicity (122,123), raising the possibility that C. 
elegans may adopt a protective mechanism to withstand an environmental challenge 
of toxic Cu by sequestering Cu to an intracellular location via CUA-1.1. 
 Unexpectedly, we observed that CUA-1.1 expression is upregulated in 
response to dietary Cu deficiency in the hypodermis when expressed under the 
control of an endogenous promoter. Given that CUA-1.1 abundance was not altered 
under the dpy-7 promoter, and that cua-1 transcript levels increased under Cu-limiting 
conditions, hypodermal cua-1 may respond to Cu deficiency transcriptionally. MTF-1 
is known to transcriptionally induce both ATP7 and metallothionein expression in 





1 independent metal-responsive transcription factors have been identified, suggesting 
the existence of other Cu-responsive transcription factors that could regulate cua-1 
expression in the hypodermis (68,122). CUA-1 in the hypodermis may deliver Cu to 
the secretory pathway for Cu incorporation into Cu-dependent enzymes. Another 
possibility is that the hypodermis acts as a Cu storage compartment that can release 
Cu to peripheral tissues by increasing CUA-1.1 expression when worms are in a Cu-
deficient environment. When CUA-1.1 is highly expressed in the hypodermis under 
dietary Cu restriction, most CUA-1.1 localizes to plasma membranes. Notably, the 
hypodermis is known to act as a major fat storage site in worms by accumulation of 
lipid droplets (128,129).  
Organs communicate to ensure that intestinally derived micronutrients are 
distributed appropriately throughout tissues in the body, balancing cellular 
requirements against toxicity (8,9). We injected Cu into the pseudocoelom of adult 
worms expressing CUA-1.1::GFP that had been precultured with BCS. Interestingly, 
worms injected with Cu showed a punctate distribution of CUA-1.1::GFP, implying 
that the mechanism of CUA-1.1 responds to Cu status in the pseudocoelom, or/and 
Cu overload peripheral tissues. In mammals, Fe overload results in the liver 
producing elevated levels of secreted hepcidin peptide that interacts with the 
ferroportin Fe exporter on the basolateral membrane of intestinal epithelial cells as 
well as on macrophages, decreasing Fe entry into blood through internalization of 
ferroportin (9,130). In C. elegans, several neuropeptides are known to mediate 
intestinal function to regulate metabolism and development (131-133), while a 





importer in the heart induced a significant upregulation of ATP7A in the intestine of 
mice, which may lead to increased Cu supply into circulation (61). This study 
suggested that a cross-talk may take place among tissue types for systemic Cu 
homeostasis. In C. elegans, while enterocyte-autonomous Cu homeostasis regulation 
may result in a sufficient organismal Cu balance in general, another possibility is that 
intestinal CUA-1.1 is regulated via an inter-organ communication network. A cellular 
component responsible for Cu-induced CUA-1.1 trafficking in the intestine may be 
the molecular link by which the enterocytes sense and respond to extraintestinal Cu 
status. Future studies to characterize how intestinal Cu acquisition and distribution is 
regulated at the systemic level may lead to the discovery of new pathways of 







Chapter 4: Organ-specific Regulation of ATP7A Abundance     
is Coordinated with Systemic Cu Homeostasis 
 
Summary 
Cu is an essential trace element required for a vast array of cellular processes 
in organisms from bacteria to humans. Cu serves as a redox-reactive, catalytic 
cofactor in the enzymatic reactions that drive oxidative phosphorylation, iron (Fe) 
acquisition, protection from oxidative stress, neuropeptide maturation, blood clotting, 
and angiogenesis(1-3). However, the ability of Cu to undergo reversible redox 
changes also makes this element deleterious to the organism when present in excess 
(4,5). Because of its dichotomous potential as both an essential cofactor and a toxic 
agent, cells have evolved sophisticated mechanisms for the regulation of Cu 
acquisition, storage, and distribution (6,7). As all organismal Cu must pass through 
the intestine prior to distribution to other tissues (15,58), cross-talk must take place 
among tissue types to ensure that import and export of Cu from the intestine are 
coordinated with extraintestinal Cu requirements.  
Cu is taken up by intestinal epithelial cells (IECs), routed for incorporation 
into Cu-dependent proteins, and mobilized across the basolateral membrane into 
peripheral circulation. Ctr1 is a homotrimeric integral membrane protein conserved in 
eukaryotes ranging from yeast to humans that drives intestinal Cu absorption with 





transporting P-type ATPase known as ATP7A conveys it across the basolateral 
membrane of the enterocyte, where it is delivered into portal circulation. The ATP7B 
Cu exporter, which is structurally related to ATP7A, is expressed in the liver and 
removes excess Cu via transport across the apical membrane into the bile (134).  
In humans, mutations in the ATP7A gene are known to cause Menkes disease 
(100), which often leads to early childhood mortality as a consequence of reduced Cu 
efflux from enterocytes into the bloodstream (135,136). ATP7A is normally localized 
to the trans-Golgi network (TGN) (137) where it is essential for the insertion of Cu 
into important secreted enzymes such as tyrosinase (138) and lysyl oxidase (139).  
When Cu is abundant, ATP7A-containing vesicles traffic to the plasma membrane for 
Cu efflux (137). The Cu-induced trafficking of ATP7A has presumably evolved to 
allow this transporter to shift its function from metallation of secreted cuproenzymes 
in the TGN to the cellular-protective export of excess cellular Cu across the plasma 
membrane, as well as for absorption of dietary Cu by enterocytes in the intestine. 
In contrast to other organisms, systemic Cu fluctuations in mammalian cells 
do not alter expression of Cu homeostasis genes at the transcriptional level (7). While 
it is generally accepted that regulation of mammalian Cu homeostasis at the cellular 
level occurs predominantly via posttranscriptional mechanisms, these mechanisms 
have not yet been shown to play a role in organism-wide systemic Cu homeostasis. In 
this study, we present evidence that low Cu levels stimulate a reduction in ATP7A 
protein abundance in tissue cultures and a whole animal model. Specifically, Cu-
deficient mice exhibited substantially reduced ATP7A steady-state protein levels in 





cell culture data. Compared to peripheral tissues, however, ATP7A expression in the 
intestine was inversely regulated in response to Cu levels, hinting at a distinct 
regulatory role for intestinal ATP7A in organismal Cu homeostasis. Our data suggest 
that this intestine-specific regulation of ATP7A protein levels may serve as a key 
homeostatic mechanism for control of the efflux of this essential, yet potentially 
toxic, trace element into circulation, thus providing new molecular insights into how 
intestinal Cu export is regulated for systemic Cu homeostasis in response to 
peripheral Cu deficiency. 
 
Results 
Elevated Cu increases ATP7A protein levels in cultured cells 
To explore Cu-responsive regulation of ATP7A, non-polarized rat intestinal 
epithelial cells (IEC-6) were grown in basal media and treated with CuCl2 (100 µM), 
the membrane impermeable Cu(I)-specific chelator bathocuproine disulfonic acid 
(BCS, 300 µM), or 300 µM BCS together with 100 µM CuCl2, and analyzed for 
ATP7A abundance by immunoblotting. A significant elevation in ATP7A protein 
levels was observed in media containing 100 µM Cu, whereas ATP7A levels were 
decreased in BCS-treated cells (Fig. 4.1A-B). Notably, mRNA levels of Atp7a were 
not altered by either treatment (Fig. 4.1C). ATP7A levels were enhanced in cells 
treated simultaneously with BCS and CuCl2 indicating that the BCS-induced ATP7A 
decrease is caused by a Cu-limitation. Increased levels of the Cu chaperone for 





available cellular Cu was limited, as CCS is elevated when Cu is scarce (33,34). 
ATP7A levels in IEC-6 cells were increased in response to 100 µM CuCl2 in a time-
dependent manner (Fig. 4.3A), in agreement with a previous report by the Collins 
group (140). Abundance of an ectopically-expressed recombinant-tagged (HA-GFP) 
ATP7A by Cu and BCS was regulated similarly to endogenous ATP7A (Fig. 4.2). 
To determine the sensitivity of ATP7A elevation during Cu surplus conditions, 
IEC-6 cells were pre-grown in BCS-treated media for 6 h, washed with phosphate-
buffered saline (PBS), and exposed to a range of Cu concentrations for 2 h, followed 
by assessment of ATP7A levels. Cu levels as low as 1 µM were sufficient to enhance 
expression of ATP7A as compared to cells in BCS-treated media, and ATP7A levels 
progressively increased until reaching saturation at treatment with 10 µM of Cu (Fig. 
4.3B), which is within the physiological range of Cu concentrations in plasma (141).   
To test the specificity of ATP7A metal-responsiveness, ATP7A levels were 
investigated in media containing 200 µM FeCl3, ZnCl2, MnCl2, or 10 µM AgNO3; 
exposure to iron, zinc, and manganese at a 2:1 molar excess over Cu resulted in no 
substantial increase in ATP7A protein levels (Fig. 4.3C). However, ATP7A levels 
were increased by treatment with 10 µM Ag with similar efficiency to equimolar 
concentrations of Cu. As Ag(I) is isoelectronic to Cu(I), these findings suggest that 
Cu(I), rather than Cu(II), is the primary driver of this process. 
To further explore this phenomenon in primary cells, hepatocytes were 
isolated from the livers of C57BL/6 mice at postnatal day 12 (P12), as hepatic Cu 
content and ATP7A expression levels in perinatal mice are higher than those in adult 





Figure 4.1. Cu levels affect ATP7A protein abundance. (A) IEC-6 cells were 
exposed to basal medium, 100 µM CuCl2 for 3 h, 300 µM BCS for 6 h, or 300 µM 
BCS plus 100 µM CuCl2 for 6 h. Total protein extracts were probed with an anti-
ATP7A antibody, anti-CCS, and anti-GAPDH as a loading control. A representative 
immunoblot of seven independent experiments is shown here. (B-C) Relative 
expression levels of ATP7A protein (B) and Atp7a mRNA (C) in IEC-6 cells exposed 
to CuCl2, BCS, or BCS with CuCl2 were normalized to basal media conditions from 
four independent immunoblot and RT-qPCR experiments. GAPDH protein and 18S 
rRNA mRNA, respectively, were used as internal controls in these experiments. Error 
bars indicate mean ± SD of four independent experiments. Means that do not share a 
letter are significantly different (P<0.05); ns, not significant (P>0.05) (one-way 






































Figure 4.2. Evaluation of anti-ATP7A antibody specificity and the regulation of 
recombinant-tagged ATP7A abundance by Cu. (A) Immunoblotting with anti-
ATP7A antibody. Total protein extracts from mouse embryonic fibroblasts (MEFs) of 
WT (ATP7A+/+) and ATP7A knock-out (ATP7A−/−) mice (106) were assayed. The 
upper panel shows immunoblot results with the anti-ATP7A antibody. The lower 
panel shows immunoblot results with anti-GAPDH antibody as a loading control. (B) 
HEK293 cells transiently transfected with an empty vector or a CMV-driven plasmid 
expressing a HA-GFP-ATP7A were exposed to basal medium, basal medium 
containing 100 µM CuCl2, or 300 µM BCS for 10 h. Whole cell lysates were 
processed for immunoblotting analysis using antibodies as indicated. Representative 






































Figure 4.3. Cu stimulates the elevation of ATP7A. (A-B) IEC-6 cells at ~60% 
confluence were preincubated with 300 µM BCS-treated medium for 6 h to minimize 
expression levels of ATP7A. Cells were further supplemented with 100 µM CuCl2 for 
the indicated time (A) or with the indicated Cu concentrations for 2 h (B). β-actin and 
GAPDH levels shown in the lower panel demonstrate equal protein loading. Data are 
representative of two (A) and three (B) independent experiments. (C) IEC-6 cells 
were preincubated with 300 µM BCS for 3 h before switching to media containing 
200 µM of FeCl3 (Fe), ZnCl2 (Zn), MnCl2 (Mn), 10 µM of AgNO3 (Ag), or 10 or 100 
µM of CuCl2 (Cu) for 2 h, and 100 µg of protein extracts were subjected to 
immunoblotting. Reduced levels of CCS indicate increased bioavailable Cu levels, 
and GAPDH levels are shown to indicate protein loading of samples. Immunoblots 

























Figure 4.4. ATP7A abundance is increased by Cu in primary cell lines. (A) 
Mouse primary hepatocytes treated with Cu supplementation were analyzed by 
immunoblotting. Mouse hepatocytes were pretreated for 12 h in BCS-containing 
medium and then exposed to medium containing indicated concentrations of CuCl2 
for additional 12 h. GAPDH levels were assayed as a loading control. Immunoblots 
are representative results of four independent experiments. (B) Total Cu levels in 
mouse primary hepatocytes were measured by ICP-MS upon supplementation with 
100 µM BCS or the indicated Cu concentrations. Data are presented as mean ± SD 
from four biological replicates. Values with one different letter are significantly 
different from each other (P<0.05) (One-way ANOVA, Tukey’s post hoc test). (C) 
Immunoblotting of ATP7A and Ctr1 levels in HUVEC cells treated with a range of 
concentrations of CuCl2 for 12 h. The arrowheads labeled g and t indicate the full-
length glycosylated monomer and the amino-terminal truncation forms of Ctr1, 
respectively. The glycosylated and truncated form of Ctr1 have previously been 
demonstrated to represent mature glycosylated Ctr1 species, and amino-terminal 



















Figure 4.5. ATP7A protein levels in Ctr1+/+ and Ctr1-/- MEFs. Total protein 
extracts isolated from wild type (Ctr1+/+) MEFs, Ctr1-/- MEFs transfected with empty 
vector (vec) exposed to basal media or 100 µM CuCl2 for overnight (vec+Cu), and 
Ctr1-/- MEFs transfected with a plasmid expressing Ctr1 were resolved by SDS-

















































Isolated hepatocytes were pretreated with BCS overnight and exposed to a range of 
Cu concentrations. The primary cells treated with as low as 0.5 µM Cu showed 
significantly increased ATP7A protein abundance (Fig. 4.4A) demonstrating that 
increased cellular Cu levels, as shown by ICP-MS analysis (Fig. 4.4B), are associated 
with elevated ATP7A expression. Moreover, low micromolar Cu (1 µM) was also 
sufficient to induce ATP7A expression in human umbilical vein endothelial cell 
(HUVEC) cultures (Fig. 4.4C), and levels of the Ctr1 Cu importer were significantly 
decreased upon Cu treatment, as described previously in HEK293 cells (15). These 
results demonstrate that cells harbor a mechanism for regulation of ATP7A protein 
levels to adjust the export of Cu in response to exogenous Cu. Although elevation of 
ATP7A occurs in response to Cu media supplementation, it is unclear whether 
extracellular Cu triggers this process indirectly, or whether Cu in the growth media 
enters cells and elevates intracellular Cu, thereby triggering ATP7A stabilization.  
In order to clarify the mechanism, we investigated the degradation of ATP7A 
in mouse embryonic fibroblasts (MEFs) lacking the high-affinity Cu importer Ctr1 
(Ctr1-/-) (22), along with Ctr1+/+ wild type cells, and Ctr1-/- cells transfected with a 
wild type Ctr1-expressing plasmid, grown in Cu-supplemented media (Fig. 4.5). 
ATP7A protein levels in Ctr1-/- MEF cells transfected with vector plasmid were lower 
than those in Ctr1+/+ MEFs and Ctr1-/- MEFs treated with exogenous Cu, indicating 








Post-translational control of ATP7A abundance in response to Cu 
A previous report showing no changes in ATP7A mRNA levels in response to 
supplemental Cu in rat IECs (140) suggests steady-state ATP7A protein levels are 
regulated post-transcriptionally. ATP7A is very stable protein, with a reported half-
life over 40 h in a variety of cells (140,145-147). To further explore Cu-dependent 
ATP7A regulation, IEC-6 cells were treated with Cu or BCS in the presence of the 
translation inhibitor cycloheximide (CHX), and steady-state levels of ATP7A were 
analyzed by immunoblotting over time. In IEC-6 cells, elevated steady-state levels of 
ATP7A by Cu treatment were significantly diminished within an hour of exposure to 
300 µM BCS; no reduction in ATP7A was observed under Cu-excess conditions 
upon 100 µM Cu treatment (Fig. 4.6A). 
To test whether this enhanced turnover of ATP7A occurs through the 
proteasome pathway, IEC-6 cells pretreated with Cu were exposed to BCS along with 
the proteasome inhibitors MG132 and bortezomib, alone or in combination. These 
proteasome inhibitors partially abrogated the decrease in steady-state levels of 
ATP7A protein in response to cellular Cu deprivation (Fig. 4.6B), suggesting that the 
reduction in ATP7A protein levels was due, at least in part, to increased proteolysis 









Figure 4.6. Cu-deficiency stimulates the degradation of ATP7A protein. (A) IEC-
6 cells pretreated with media containing 100 µM CuCl2 for 2.5 h were further treated 
with 50 µg/mL cycloheximide (CHX). Following 30 min incubation, cells were 
exposed to fresh culture media containing 300 µM BCS and 50 µg/ml CHX and then 
lysed after 0.5, 1, 3, or 6 h (lanes 3-6). Whole cell lysates were processed for 
immunoblotting analysis using antibodies as indicated. Immunoblot images are 
representative results of four independent experiments. (B) IEC-6 cells were 
pretreated with media containing 100 µM CuCl2 for 1 h before addition of 20 µM 
MG132, 100 nM bortezomib, or DMSO (vehicle control) and treated for another 90 
min. Cells were further treated with 50 µg/mL CHX for 30 min, and then the media 
was replaced with fresh media containing 300 µM BCS and 50 µg/mL CHX for 2 h in 
the presence of MG132 and/or bortezomib, or DMSO. Na+/K+-ATPase served as a 






























A liver-specific role for active Cu sequestration 
To test the physiological significance of Cu-responsive ATP7A abundance 
regulation, C57BL/6 mice were subcutaneously (SQ) administered Cu or saline (15) 
at P7 for three consecutive days. Mice were dissected at P10 and assayed for Cu 
accumulation in tissues by ICP-MS. While no marked Cu accumulation was observed 
in the serum or the heart, the liver showed highly elevated Cu accumulation in a dose-
dependent manner (Fig. 4.7A-C). As metallothionein (MT) genes are induced by high 
Cu exposure (148), mRNA levels of MT-1 and MT-2 genes were assessed to explore 
whether these correlate with hepatic Cu accumulation. As expected, while expression 
of MT-1 was modestly increased only in mice administered Cu at the concentration of 
10 µg/g BW, MT-2 gene was significantly elevated in mice administered SQ Cu 
compared to control mice (Fig. 4.7D-E). Hepatic ATP7A expression was enhanced 
only in mice administered Cu at the concentration of 10 µg/g total body weight (BW) 
(Fig. 4.8A). Elevated serum Cu levels were also detected only in mice treated with 10 
µg Cu/g BW (Fig. 4.7A), suggesting that this level of Cu exceeds the capacity of the 
liver to excrete surplus Cu.  
As the Cu-specific importer Ctr1 is inactivated through endocytosis and 
degradation in cultured cells in response to Cu treatment (Fig. 4.4C) (25), and the 
mature glycosylated form of Ctr1 was increased in the intestines and hearts of wild 
type mice fed a Cu-deficient diet (23), we performed immunoblot analysis of Ctr1 
protein levels in the livers of mice administered with Cu. Unexpectedly, whereas 





Figure 4.7. Hepatic Cu accumulation is preferentially elevated by subcutaneous 
Cu administration. (A-C) Cu levels measured by ICP-MS in serum (A), hearts (B), 
and livers (C) from C57BL/6 mice (P10) SQ administered indicated amounts of Cu-
histidine for three consecutive days beginning at P7. Data (means ± SD) are from 
seven to nine mice of each condition (n = 2-5 mice for males and females per Cu 
dose), and means marked with different letter superscripts are significantly different 
at p=0.05 (one-way ANOVA, Tukey’s post hoc test). (D-F) Quantitative RT-qPCR 
analysis of mRNA levels of Mt1, Mt2, and Ctr1. Levels of Mt1 (D), Mt2 (E), Ctr1 (F) 
transcripts were measured relative to Gapdh mRNA levels in the livers of individual 
mice at P10 (male, n = 2; female, n = 2) for each condition, which were SQ 
administered Cu or saline at P7 for three consecutive days. Bars indicate mean ± SD 
for each condition. Means that do not share a letter are significantly different 



































Figure 4.8. Hepatic Ctr1 protein levels are elevated by subcutaneous Cu 
administration. (A-B) Immunoblot analysis of ATP7A, Ctr1, CCS, and GAPDH in 
liver (A) and heart (B) extracts from two representative mice administered saline or 
indicated amounts of Cu-histidine per body weight (µg/g) for three consecutive days 
beginning at P7. The arrowheads indicate the glycosylated full-length (g) and 
truncated form (t) of Ctr1, respectively. GAPDH levels were assayed as a loading 
control. Results are representative of three to four independent experiments 
performed on a total of male (liver, n = 5, 4, 4, and 6; heart, n = 5, 3, 5 and 6) and 
female mice (liver, n = 6, 4, 4, and 5; heart, n = 6, 4, 2, and 5), which were SQ 





























Figure 4.9. Ctr1 protein levels in the heart, spleen, brain, and liver from WT 
mice SQ administered saline or Cu. Immunoblot analysis of ATP7A, Ctr1, CCS, 
and β-actin in the heart, spleen, brain, and liver extracts from two representative mice 
administered with saline or 10 µg of Cu-histidine per body weight (g) for three 
consecutive days beginning at P7. The arrowheads indicate the full-length 
glycosylated (g) and truncated form (t) of Ctr1, respectively. β-actin levels were 
assayed as a loading control. Data shown here are representative of three to four 
independent experiments performed for each tissue of male (M) (liver, n = 5 and 6; 
heart, n = 5 and 6; brain, n = 2 and 2; spleen, n = 3 and 4) and female (F) mice (liver, 
n = 6 and 5; heart, n = 6 and 5; brain, n = 2 and 2; spleen, n = 3 and 2), which were 






































of Ctr1 protein was strongly elevated in the livers of Cu-treated mice, with a 
concomitant increase in hepatic Cu accumulation and a reduction in CCS levels, in a 
dose-dependent manner (Fig. 4.7C and Fig. 4.8A). However, peripheral tissues such 
as the heart, spleen and brain showed no obvious changes in protein abundances of 
Ctr1 and ATP7A (Fig. 4.8B and Fig. 4.9). These data suggest that Cu-responsive 
elevation of the mature glycosylated Ctr1 protein is liver-specific, suggesting a 
mechanism by which Cu can be sequestered in the liver under Cu-excess conditions. 
Taken together, these findings suggest the existence of a liver-specific role for Ctr1 in 
active Cu detoxification for systemic Cu homeostasis. 
 
Organ-specific regulation of ATP7A abundance 
The administration of Cu treatment in C57BL/6 mice did not lead to robust 
changes in Cu levels in the circulation (Fig. 4.7A) and resulted in an increase in 
ATP7A levels in the liver only in mice administered Cu at the concentration of 10 
µg/g BW (Fig. 4.8A) compared to those in cell culture models (Fig. 4.4A) despite 
comparable cellular Cu levels between the in vitro (Fig. 4.4B) and in vivo (Fig. 4.7C) 
experimental conditions. We therefore postulated that the tissues of Cu-deficient mice 
may be more sensitive to Cu fluctuations in circulation than those from Cu-adequate 
wild-type mice. To test this hypothesis, we utilized the intestine-specific Ctr1 
knockout mouse (Ctr1int/int) as a Cu-deficient animal model. Ctr1 knockout in the 
intestine markedly reduces Cu accumulation in peripheral tissues including the liver, 
heart, and spleen, and results in severe Cu deficiency phenotypes at P10 (15,23). P10 





the steady-state levels of Cu in several peripheral tissues of Ctr1int/int and control mice 
(Ctr1flox/flox) administered with Cu or saline were evaluated by ICP-MS. As shown in 
Fig. 4.10, Ctr1int/int mice demonstrated significantly reduced Cu accumulation in all 
peripheral tissues tested. Consistent with previous data, the intestine of Ctr1int/int mice 
hyperaccumulated Cu in a non-bioavailable pool(15), as supported by elevated CCS 
abundance representing reduced bioavailable Cu levels (Fig. 4.14A and Fig. 4.14C).  
To explore whether fluctuations in Cu concentrations in peripheral tissues are 
associated with changes in ATP7A protein expression levels, we examined ATP7A 
levels from Ctr1int/int and Ctr1flox/flox pups administered with Cu or saline injections. 
ATP7A levels in the peripheral tissues (such as the livers) of Ctr1int/int mice were 
clearly decreased as compared to those in age-matched sibling control mice 
(Ctr1flox/flox); however, this decrease in ATP7A levels was rescued to the levels found 
in control Ctr1flox/flox mice by SQ Cu administration (Fig. 4.11A-B). Hyper-
accumulated Fe levels in the intestine and liver, likely due to a reduction of Fe efflux 
facilitated by the Cu-dependent ferroxidase hephaestin and ceruloplasmin (15), were 
also rescued by Cu administrations in these mice (Fig. 4.12). The abundance of 
hepatic ATP7B protein was not changed by Cu injection or Cu deficiency (Fig. 
4.11A), which is consistent with recent observations that elevated Cu levels in the 
body alters the cellular localization of ATP7B from the TGN to lysosomes without 
any concomitant change in ATP7B protein levels (149).  
While Cu deficiency did not affect Ctr1 abundance in the livers of Ctr1int/int 





Figure 4.10. Relative Cu levels in control and Ctr1int/int mice SQ administered 
saline or Cu-histidine. Relative Cu levels in liver extracts, serum, intestinal 
epithelial cells (IEC), and total brain extracts of control mice (Ctr1flox/flox or Ctr1flox/+) 
and Ctr1int/int mice SQ administered saline or 10 µg of Cu-histidine per body weight 
(g) at P10, normalized to those of control (Ctr1flox/flox or Ctr1flox/+) mice administered 
saline. Data are shown as relative fold change compared with control (means ± SD) 
from seven to nine mice per condition (n = 2-5 mice per sex per condition), and 
means followed indicated with different letter superscripts are significantly different 







































Figure 4.11. Systemic Cu status regulates ATP7A protein levels in the liver. (A) 
Representative Ctr1flox/flox and Ctr1int/int mice littermates SQ administered saline or 
Cu-histidine at P10 and sacrificed at P12 for analysis. Protein extracts from the 
indicated tissues from these mice were immunoblotted with anti-ATP7A, anti-CCS, 
anti-ATP7B, anti-Ctr1, and anti-GAPDH antibodies. The arrowheads labeled g and t 
indicate the full-length glycosylated, and truncated forms of Ctr1, respectively. Data 
shown here are representative of three to eleven independent experiments performed 
for each mouse tissue (liver, n = 12, 10, 12, and 10). (B-C) Quantification of ATP7A 
and CCS expression in Ctr1flox/flox and Ctr1int/int mice administered with saline or Cu. 
Relative protein abundances of hepatic ATP7A (B) and CCS (C) were quantified by 
analyzing immunoblots of 10-12 mice tissues (liver, n = 12, 10, 12, and 10) for each 
condition for statistical analysis. Error bars represent average ± SD, and means 
indicated with different letters are significantly different from each other at p=0.05 
































Figure 4.12. Relative Fe levels in control and Ctr1int/int mice SQ administered 
saline or Cu-histidine. Relative Fe levels in liver extracts, serum, intestinal epithelial 
cells (IEC), and total brain extracts of control mice (Ctr1flox/flox or Ctr1flox/+) and 
Ctr1int/int mice SQ administered saline or Cu-histidine at P10, normalized to those of 
control (Ctr1flox/flox or Ctr1flox/+) mice administered saline. Data are shown as relative 
fold change compared with control (means ± SD) from seven to nine mice per 
condition (n = 2-5 mice per sex per condition), and means indicated with different 
letter superscripts are significantly different at p=0.05 (two-way ANOVA, Tukey’s 







































Figure 4.13. Systemic Cu status regulates ATP7A protein levels in heart and 
spleen. (A and D) Representative Ctr1flox/flox and Ctr1int/int mice littermates SQ 
administered saline or Cu-histidine at P10 and sacrificed at P12 for analysis. Protein 
extracts from the indicated tissues from these mice were immunoblotted with anti-
ATP7A, anti-CCS, and anti-GAPDH antibodies. Data shown here are representative 
of three to eleven independent experiments performed for each mouse tissue (heart, n 
= 6, 6, 4, and 4; spleen, n = 6, 4, 9, and 4). (B, C, E, and F) Relative protein 
abundances of ATP7A (B-C) and CCS (E-F) were quantified by analyzing 
immunoblots of each tissue from mice (heart, n = 6, 6, 4, and 4; spleen, n = 6, 4, 9, 
and 4) for each condition for statistical analysis. Error bars represent average ± SD, 
and means indicated with different letters are significantly different from each other 



































treated Ctr1int/int and Ctr1flox/flox mice as compared to saline-treated Ctr1int/int and 
Ctr1flox/flox mice, reaffirming that the liver acts as a Cu storage and sequestration organ 
under Cu overload conditions. Increased CCS in the livers of Ctr1int/int pups due to Cu 
deficiency was suppressed by Cu administration, (Fig. 4.11A and Fig. 4.11C), 
consistent with the ICP-MS analysis (Fig. 4.10). ATP7A levels in several other 
peripheral tissues including the hearts and spleens similarly exhibited reduced 
ATP7A levels in Ctr1int/int mice as compared to Ctr1flox/flox mice, and these levels were 
restored by Cu administration (Fig. 4.13). These in vivo findings suggest that ATP7A 
protein abundance in several peripheral organs is regulated in response to Cu levels in 
animals. 
 
Intestinal ATP7A protein abundance primarily responds to systemic Cu status 
Since intestinal Cu absorption is the primary point at which Cu transport into 
circulation can be regulated, we examined the expression levels of ATP7A in 
intestinal enterocytes in Ctr1- and Cu-deficient mice. Interestingly, intestinal ATP7A 
abundance was inversely correlated with bioavailable Cu, in direct opposition to its 
regulation in the liver (Fig. 4.11A-B and Fig. 4.14A-B). While bioavailable Cu was 
limited in the intestinal epithelial cells, as indicated by increased levels of CCS (Fig. 
4.14A and Fig. 4.14C) ATP7A expression was strongly elevated as compared to that 
in saline-treated Ctr1flox/flox mice; this elevated ATP7A was suppressed by Cu 
administration, leading to increases in bioavailable Cu in the intestine and other 
tissues as compared to that in saline-treated Ctr1int/int mice (Fig. 4.14A-C). Elevated 





indicating that bioavailable Cu was increased in the enterocytes in Ctr1int/int mice 
administered with Cu (Fig. 4.10, Fig. 4.14A, and Fig. 4.14C) (2,15,150). This result 
was not anticipated, as our Ctr1-/- MEFs results (Fig. 4.15) indicate that bioavailable 
Cu levels in enterocytes are severely limited, which would lead to decreased ATP7A 
levels. Enterocytes displayed the opposite response when compared to that of cultured 
cells and peripheral tissues. These intriguing observations suggest that while ATP7A 
acts to manage intracellular Cu homeostasis in peripheral tissues, intestinal ATP7A 
levels are at least partially determined by extraintestinal Cu status. 
To further explore the in vivo regulation of ATP7A abundance under different 
Cu availability, ATP7A mRNA levels in mouse tissues were measured by reverse 
transcription quantitative PCR (RT-qPCR). ATP7A steady-state mRNA levels did not 
significantly change in either the livers or the intestines of Ctr1int/int and Ctr1flox/flox 
mice administered Cu or saline (Fig. 4.16). This indicated that control of ATP7A 
abundance in response to Cu occurs post-transcriptionally, similar to regulation in cell 
cultures (Fig. 4.1) and reminiscent of the dramatic changes in ATP7A protein, but not 
mRNA, in the intestine caused by cardiac-specific loss of Ctr1 in mice (Ctr1hrt/hrt) (61) 
(Fig. 4.17). Taken together, these results demonstrate that intestinal epithelial cells 
control ATP7A protein abundance via post-transcriptional regulation in response to 
peripheral tissue Cu deficiency. 
The diametrically contrasting effects of Cu deficiency on ATP7A expression 
in peripheral tissues compared to enterocytes raises the question as to what 





Figure 4.14. Reduced levels of systemic Cu increase ATP7A protein levels in 
enterocytes. (A) Representative Ctr1flox/flox and Ctr1int/int mice littermates SQ 
administered saline or Cu-histidine at P10 and sacrificed at P12 for analysis. Protein 
extracts from the indicated tissues from these mice were immunoblotted with anti-
ATP7A, anti-CCS, anti-Ctr1, and anti-GAPDH antibodies. The arrowheads labeled g 
and t indicate the full-length glycosylated, and truncated forms of Ctr1, respectively. 
Data shown here are representative of three to eleven independent experiments 
performed for each mouse tissue (enterocytes, n = 22, 20, 22, and 22). (B-C) 
Quantification of ATP7A and CCS expression in Ctr1flox/flox and Ctr1int/int mice 
administered with saline or Cu. Relative protein abundances of hepatic ATP7A (B) 
and CCS (C) were quantified by analyzing immunoblots of 20-22 mice tissues 
(enterocytes, n = 22, 20, 22, and 22) for each condition for statistical analysis. Error 
bars represent average ± SD, and means indicated with different letters are 
































Figure 4.15. ATP7A protein levels in response to Cu status in isolated and 
cultured enterocytes. (A) Cu-responsiveness of isolated Ctr1int/int enterocytes 
cultures. Isolated enterocytes from Ctr1flox/flox and Ctr1int/int mice were cultured in 
medium containing 100 µM CuCl2 or 300 µM BCS for 2 h. Total protein extracts of 
cultured enterocytes were subjected to SDS-PAGE and analyzed by immunoblotting. 
Immunoblots shown here are representative of three independent experiments 
performed on a total of n = 5, 5, 7, and 7. (B-C) Relative protein abundances of 
ATP7A (B) and CCS (C) were quantified by analyzing immunoblots of each tissue 
from mice (isolated enterocytes culture, n = 5, 5, 7, and 7) for each condition for 
statistical analysis. Error bars represent average ± SD, and means indicated with 
different letters are significantly different from each other at p=0.05. ns, not 






































Figure 4.16. Quantitative RT-qPCR analysis of Atp7a mRNA levels in the liver 
and intestine of Ctr1flox/flox and Ctr1int/int mice SQ administered saline or Cu. 
Levels of Atp7a mRNA relative to Gapdh mRNA levels in the livers (A) and 
intestinal epithelial cells (B) from the Ctr1flox/flox and Ctr1int/int mice two days 
following SQ administration of saline or 10 µg of Cu-histidine per body weight (g) at 
P10 were determined on a total of male (n = 2, 3, 3, and 2) and female (n = 4, 2, 3, 
and 3) mice. Bars indicate mean ± SD of five to six mice for each condition. ns, not 









































Figure 4.17. Protein and mRNA levels of intestinal ATP7A in cardiac-specific 
Ctr1 knockout mice. Protein abundances (A) and mRNA levels (B) of ATP7A in 
intestinal cells in Ctr1hrt/hrt and Ctr1flox/flox mice were measured by immunoblot 
analysis and RT-qPCR. A representative result of three independent immunoblots for 
ATP7A is shown in (A). For RT-qPCR, Atp7a and Gapdh mRNA levels from five 
mice (male, 2 and 3; female, 3 and 2) for each condition were determined. Error bars 







































Figure 4.18. ATP7A protein levels in polarized IEC-6 cells treated with Cu or 
BCS. IEC-6 cells were grown on trans-well culture systems until they had formed 
tight junctions as a monolayer as described in Methods. Cells were treated with Cu or 
BCS for 12 h on either the apical or basolateral side of IEC-6 cells and cell extracts 
were then probed with anti-ATP7A, anti-CCS and anti-GAPDH antibodies. Shown is 









































peripheral tissues. Isolated enterocytes from Ctr1int/int and Ctr1flox/flox mice were 
exposed to culture medium treated with Cu or BCS for 2 h. Immunoblot analysis of 
these cells revealed that elevated intestinal ATP7A in Ctr1int/int mice was decreased 
by BCS treatment, concomitant with an increase in CCS expression in isolated and 
cultured enterocytes when compared to those from the Cu-treated medium (Fig. 4.15). 
Thus, when isolated in culture, enterocytes appear to regulate ATP7A expression in 
response to Cu availability in a manner that more closely resembles that of peripheral 
tissues and cultured cells than that found in enterocytes in their native milieu. Cu 
treatments of either the apical or basolateral side of polarized IEC-6 cells using a 
trans-well system led to elevation of ATP7A levels (Fig. 4.18) suggesting 
polarization per se is not sufficient to recapitulate the ATP7A phenotype shown in the 
intestine of Cu-injected Ctr1int/int (Fig. 4.14). 
To determine the subcellular distribution of the intestinal ATP7A protein in an 
in vivo model, we examined the localization of ATP7A across the duodenum and 
upper jejunum of Ctr1int/int and Ctr1flox/flox mice. Multi-label confocal 
immunofluorescence microscopy showed that ATP7A expression was specific to 
enterocytes at the villus tip (Fig. 4.19), with predominant localization of ATP7A to 
intracellular vesicles and little overlap with wheat germ agglutinin (WGA), an apical 
membrane marker (Fig. 4.20C and Fig. 4.20F). The majority of ATP7A was 
concentrated in intracellular puncta in both Ctr1int/int and Ctr1flox/flox mice, as opposed 
to the basolateral membranes (marked by the Na+/K+-ATPase). Highly elevated levels 
of ATP7A were apparent in Ctr1int/int mice as compared to control mice, confirming 





highly increased intestinal ATP7A in Ctr1int/int mice primarily localizes to 
intracellular vesicles in the enterocytes of intestinal villi, a distribution like that in 
Ctr1flox/flox mice. 
The results from the Ctr1int/int mice support the hypothesis that ATP7A 
expression in the enterocyte is controlled by the need to supply Cu to peripheral 
tissues. Alternatively, the changes to ATP7A abundance in the intestine could also be 
attributed to the intestinal loss of Ctr1 in Ctr1int/int mice, independent of peripheral Cu 
deficiency. To separate these two possibilities, we determined if intestinal ATP7A 
expression was regulated by Cu deficiency in wild-type mice in a similar manner to 
their Ctr1int/int and Crt1hrt/hrt counterparts. We performed analysis of ATP7A levels in 
mice fed Cu-adequate and Cu-deficient diets. Dietary Cu-deficiency in wild type mice 
correlated to a reduction in hepatic ATP7A expression in parallel with increased CCS 
expression resulting from Cu restriction (Fig. 4.21A). However, abundance of the 
intestinal ATP7A Cu efflux pump was significantly enhanced, even while enterocytes 
demonstrated severe Cu-deficiency, as indicated by elevated levels of CCS, like the 
observations from Ctr1int/int mice (Fig. 4.21B). Moreover, enterocytes expressed 
higher amounts of the glycosylated full-length form of Ctr1 in the intestinal epithelial 
cells of Cu-deprived mice. Together, these findings suggest an intestinal regulatory 
mechanism for dietary Cu absorption via increased expression of the Ctr1 Cu 
importer and ATP7A Cu exporter in wild type mice, and indicate that intestinal 







Figure 4.19. Confocal microscopy analysis of endogenous ATP7A in the jejunum 
from Ctr1flox/flox and Ctr1int/int mice. Sections of upper jejunum from Ctr1flox/flox (A-B) 
and Ctr1int/int mice (C) were subjected to confocal immunofluorescence microscopy 
analysis. Image (A) is obtained without adding anit-ATP7A primary antibody. Images 
are representative of two independent experiments. Green, anti-ATP7A; magenta, 










































Figure 4.20. Elevated ATP7A is enriched in intracellular vesicles in the 
enterocytes of Ctr1int/int mice. Confocal immunofluorescence images of endogenous 
ATP7A in the enterocytes of Ctr1flox/flox (A-C) and Ctr1int/int (D-F) mice (P12). Upper 
jejunum sections were subjected to confocal immunofluorescence microscopy 
analysis. Images are representative of four independent experiments. Note that B, C, 
E, and F are enlarged images. Green, anti-ATP7A; red, anti-Na+/K+-ATPase alpha-1 
subunit; magenta, anti-Wheat Germ Agglutinin (WGA, 15 µg/mL); blue, DAPI. Scale 




































Figure 4.21. Dietary Cu-deficient mice exhibit elevated protein levels of ATP7A 
and Ctr1 in the intestine. (A-B) Immunoblot analysis of ATP7A and CCS in the 
liver (A) and enterocytes (B) of three representative mice (P15) fed a control or Cu-
deficient diet. GAPDH levels were assayed as a loading control. The arrowheads 
labeled g and t indicate the glycosylated full-length, and truncated forms of Ctr1, 
respectively. Data shown in here are representative of three independent experiments 
performed on male (n = 3 and 3) and female (n = 2 and 4) mice for Cu-adequate and 



















































The unique physiological functions and specific cell types found in various 
mammalian organ systems result in differential demands for Cu. The role of the Cu 
exporter ATP7A in cellular Cu delivery to secretory pathways and into peripheral 
circulation in organisms has been well established via its Cu-responsive trafficking 
(7,50,101,137,151). However, the mechanisms by which ATP7A abundance in 
distinct tissues responds to changes in organismal Cu remain poorly understood 
(2,61,100). Here we present data that suggest ATP7A abundance is an important 
control point for Cu homeostasis in peripheral tissues including the heart and spleen; 
in mice, excess Cu results in increased ATP7A protein levels in liver tissue, 
consistent with a need to prevent over-accumulation of this metal through enhanced 
ATP7A-driven Cu export. Our data demonstrate that in response to potentially 
detrimental Cu concentrations, cell systems not only relocate ATP7A to post-Golgi 
vesicles and the plasma membrane (137), but also increase the protein abundance of 
ATP7A in order to enhance export of Cu from cells and restore intracellular Cu 
homeostasis (Fig. 4.1-6) (140). Conversely, under Cu deficiency, our results suggest 
that ATP7A protein abundance is reduced, at least in part, by the proteasome system 
(Fig. 4.6B), consistent with a reduced need to export Cu from the cell. It is worth 
noting that Cu status regulates the multi-Cu oxidase hephaestin via a proteasome-
mediated pathway (152), and that XIAP targets CCS for ubiquitination through its E3 
ubiquitin ligase activity, resulting in the degradation of CCS under adequate levels of 
Cu (35). It is possible that a similarly-regulated E3 ubiquitin ligase binds to ATP7A 





While it is known that the liver is a major Cu storage organ in mammals, little 
attention has been paid to the delineation of the biochemical mechanisms by which 
mammals regulate the detoxification, storage, and mobilization of Cu (153). We 
observed that Cu accumulation is drastically increased in the liver as compared to 
other peripheral tissues in mice administered SQ Cu (Fig. 4.7C and Fig. 4.10), 
supporting the concept of the liver as the principle Cu storage organ. Ctr1 is known to 
be internalized and degraded in response to high Cu levels in cultured cells (25), 
which we also observed in this study (Fig. 4.4C). Unexpectedly, the liver 
demonstrated an increase in Ctr1 levels in response to Cu administration when 
compared to levels in mice administered saline (Fig. 4.8A and Fig. 4.11A). This 
finding suggests that in contrast to other tissues, liver Ctr1 expression is elevated 
under high Cu conditions; this is possibly to facilitate removal of Cu from the 
circulation and prevent build up in other Cu-susceptible peripheral tissues. The 
mechanisms underlying the contrasting responses of Ctr1 in liver versus peripheral 
tissues remain to be determined. 
Unexpected observations from our analyses of Cu-deficient mice include the 
elevated protein levels of ATP7A and Ctr1 in enterocytes associated with limited 
levels of bioavailable intracellular Cu, while under these same conditions, peripheral 
tissues showed significantly diminished ATP7A expression. In addition, while Cu 
accumulation significantly increased in the enterocytes of Ctr1int/int mice, SQ Cu 
administration into these mutant mice suppressed intestinal ATP7A expression. A 
previous study revealed that cardiac-specific Ctr1 ablation in mice (Ctr1hrt/hrt) results 





concomitant elevation of serum Cu levels (61). Our results raise the possibility that 
modulation of ATP7A abundance in the intestine, not the liver, is the principal means 
by which Cu supply to circulation is regulated depending upon Cu demands from 
peripheral tissues. Notably, changes in Cu levels did not alter the subcellular 
distribution of ATP7A in enterocytes. This suggests the possibility that in vivo, the 
intestine increases ATP7A abundance in intracellular vesicles to efflux Cu via 
exocytosis through basolateral membrane into circulation.  
Intestinal epithelial cells in Ctr1int/int mice administered with SQ Cu exhibited 
profound Cu accumulation in parallel with enhanced levels of bioavailable Cu as 
indicated by decreased CCS, and a rescued Fe hyper-accumulation phenotype when 
compared with control (saline-administered) Ctr1int/int mice (Fig. 4.10, Fig. 4.12, and 
Fig. 4.14). Given that Ctr1 localizes to the apical membrane in enterocytes (23), and 
intestinal Ctr1 is poorly expressed in Ctr1int/int mice (15), these observations suggest 
the existence of alternative Cu uptake machinery at the basolateral membrane of 
intestinal epithelial cells. Such a mechanism may have its origins in utero where Cu 
delivery to enterocytes might occur via Ctr1-independent serosal-to-mucosal Cu 
transport. A possible pathway in this process might be an anion exchanger-dependent 
Cu import system (30), which remains to be identified. 
Studies of cultures of isolated enterocytes from Ctr1int/int mice presented here 
show that elevated ATP7A expression in the enterocytes of Cu-deficient mice is 
suppressed in culture with BCS-treated medium (Fig. 4.15), whereas identical 
enterocytes showed stronger ATP7A expression concomitant with reduced serum Cu 





importance of the intestine as a regulator of Cu entry to the body, which must respond 
not only to intrinsic Cu needs, but those of peripheral tissues via the basolateral side 
of epithelial cells that is thought to be in direct communication with circulating 
effectors. As intestinal ATP7A levels in both Ctr1int/int (low serum Cu) (15), and 
Ctr1hrt/hrt (high serum Cu) (61) mice are elevated, the data suggest that serum Cu 
itself is not a direct intestinal ATP7A inducer. Instead, we speculate that a circulating 
factor likely regulates intestinal levels of ATP7A. Clearly, more extensive studies are 
required to identify such a molecule and its mode of action. Such studies will greatly 
expand our understanding of the regulation of systemic Cu homeostasis and human 




















Figure 4.22. Mammalian Cu homeostasis in select organs and tissue types. 
Several organs where Cu homeostasis was investigated in this study are shown, 
including liver, IECs, and heart. In the diagram of specific tissue types, the cellular 
membrane localization of Cu transporters and directionality in response to systemic 














































Chapter 5: Conclusions and Future Directions 
 
Conclusions 
Understanding how Cu status is sensed and regulated at the cellular, tissue, 
and organismal levels is critical in the process of delineating the complicated 
relationship between Cu absorption, distribution, and inter-organ trafficking. The goal 
of this project was to determine the role that Cu exporters play in systemic Cu 
homeostasis in C. elegans and mouse. The major findings of these studies are 
outlined below. 
1) We determined that the dietary Cu requirements of C. elegans showed a 
bell-shaped growth curve, with impaired growth, smaller brood size, and delayed 
development at either end of the Cu spectrum, and maximal growth in the low 
micromolar range of Cu.  
2) CUA-1, the ortholog of human ATP7A and ATP7B, is required for normal 
worm growth and larval development as a regulator of Cu homeostasis. Depletion of 
cua-1 under dietary Cu-deficient conditions results in lethality, which is fully rescued 
by supplementation of Cu in media.  
3) Worms expressing cua-1 translational fusions revealed that cua-1 is 
expressed in multiple tissues, such as intestine, neurons, pharynx, and hypodermis, 
but that this protein is found mainly on basolateral membrane of the intestinal cells 
and some neurons. Dietary Cu deficiency induces an increase of cua-1 transcript 





4) Depletion of cua-1 in the intestine resulted in reduced fecundity similar to 
that of whole-body RNAi, and RNAi depletion of either cuc-1 or cua-1 in Pvha-
6::CUA-1.1::GFP; cua-1(ok904) transgenic animals grown under low Cu results in a 
lethal phenotype that can be rescued by Cu supplementation. These results imply that 
a CUC-1/CUA-1 Cu delivery pathway (like Atox1/ATP7A in mammals) from 
intestine to peripheral tissues is essential for worms under dietary Cu restriction.  
5) While CUA-1.1::GFP localized to the basolateral membranes and TGN of 
the intestine in BCS-treated worms, dietary Cu supplementation or Cu-injection to the 
pseudocoelom resulted in a redistribution of CUA-1.1 to the gut granules. These 
changes in localization are not associated with Cu-responsive change of CUA-1.1 
abundance in the intestine. However, transgenic worms expressing Pdpy-7::CUA- 
1.1::GFP showed that in hypodermal tissues, plasma membrane localization of CUA-
1.1 was not affected by dietary Cu. Together these observations indicate that Cu-
responsive trafficking of CUA-1.1 protein is intestine-specific.  
6) Under Cu-overload conditions, CUA-1.1::GFP localized on the membrane 
of gut granules with stronger detection of labile Cu by Cu probe in vesicles. 
Inhibition of biogenesis of gut granules by pgp-2 RNAi in worms resulted in delayed 
growth and reduced Cu accumulation as well as no detection of CUA-1.1 in vesicular 
compartments. These results imply that the existence of a systemic Cu homeostasis 
mediated by the trafficking of intestinal CUA-1.1 in C. elegans, and that gut granules 
are at least partially required for Cu detoxification by CUA-1.1.  
7) CUA-1.2, another transcript of cua-1, lacking cytoplasmic N-terminus 122 





response to varying dietary Cu levels, implying that Cu-dependent trafficking of 
CUA-1.1 to gut granules is dependent on trafficking motifs within this N-terminal 
region.  
8) In mammalian cell culture, reduced Cu levels stimulate the degradation of 
ATP7A, and proteasomal degradation pathway is involved in the mechanism. These 
data indicate that, in addition to the Cu-responsive trafficking of ATP7A, regulation 
of ATP7A protein stability provides another layer of key homeostatic mechanism for 
control of the efflux of Cu.  
9) While Ctr1 is known to be degraded by elevated Cu levels in cell cultures 
and several tissues in mice, the liver showed highly increased Ctr1 protein levels with 
drastically accumulated Cu levels by SQ Cu injection, suggesting the critical role of 
liver for facilitating removal of Cu from the blood and preventing hyperaccumulation 
of Cu in the other Cu-susceptible peripheral tissues.  
10) In vivo, peripheral organs including, liver, heart, and spleen decrease 
ATP7A protein abundance under Cu-deficient condition as compared to those in age-
matched sibling control mice. These findings indicate that ATP7A protein levels in 
several peripheral organs are regulated in response to Cu levels in animals similar to 
cell culture models.  
11) In contrast to ATP7A levels in the liver, steady-state protein levels of 
ATP7A in the intestine were inversely correlated to intestinal Cu levels without 
substantial subcellular localization change; low systemic Cu increased ATP7A in the 
intestine but decreased ATP7A in peripheral tissues, suggesting an intestine-specific 





12) Data from isolated and cultured enterocytes from Ctr1int/int mice show that 
elevated ATP7A expression in the enterocytes of Cu-deficient mice is suppressed in 
BCS-treated medium. Since intestinal ATP7A abundance in both Ctr1int/int (low 
serum Cu) (15), and Ctr1hrt/hrt (high serum Cu) (61) mice are increased, the data 
imply that serum Cu status itself is not a direct intestinal ATP7A inducer. These 
findings underscore the importance of the intestine as a regulator of Cu entry to the 
body, which must respond not only to intrinsic Cu needs, but those of peripheral 
tissues, which are thought to be in direct communication with circulating factors. 
 
Future directions 
Defining the cellular pathway for Cu-regulated trafficking of CUA-1 
We found that Cu-responsive trafficking of CUA-1 in the intestine is a key 
regulatory mechanism to maintain systemic Cu homeostasis in worms, which raises 
the question as to what proteins sense high systemic Cu status and stimulate 
endosomal re-localization of CUA-1 in the intestine. In addition, given that CUA-1.2 
lacks a portion of the N-terminal regions of CUA-1.1 and is targeted constantly to the 
basolateral membrane even under higher Cu conditions, the first 122 amino acids of 
CUA-1.1 may contain necessary trafficking information for Cu responsiveness and 
correct targeting to gut granules.  
In this sub-aim, we propose RNAi screens for Cu-responsive regulators of 
CUA-1 trafficking. It has been estimated using a genome-wide screen that 657 genes 





these sorting factors might be involved in CUA-1 localization, RNAi depletion of 
these 657 trafficking regulators could be performed in worms expressing Pvha-
6::CUA- 1.1::GFP. Fluorescence microscopy will be used to discover which of these 
genes are required in Cu-dependent endocytosis of GFP-tagged CUA-1. In addition to 
these genes, worm orthologs of trafficking factors that are reported to facilitate 
human ATP7A trafficking, such as adaptor proteins and Rab GTPases, could be 
included (155-157). If RNAi-treated worms show intracellular accumulation of CUA-
1 with decreased basolateral membrane localization under Cu-deficient conditions 
(and the converse at high Cu exposure), it would suggest that the knocked-down gene 
participates in Cu-regulated CUA-1 trafficking. This aim will define the mechanisms 
of Cu stimulated CUA-1 trafficking in worms, that are likely to be conserved in 
human cells for ATP7A and ATP7B.  
 
Determination of the role of the hypodermis in Cu homeostasis in worms 
We revealed that cua-1 expression is elevated under Cu deficient conditions 
only in the hypodermis whereas subcellular localization was not altered by Cu level 
calling into the question as to what is the role of hypodermal CUA-1 in Cu 
metabolism in worms. One possible hypothesis is that CUA-1 in the hypodermis may 
deliver Cu to the TGN for Cu loading into newly synthesized Cu-dependent enzymes. 
Another possibility is that the hypodermis functions as a Cu storage tissue that can 
supply Cu to peripheral tissues by increasing CUA-1.1 expression when worms are 
undergoing Cu-deficiency. Sai Yuan, a graduate student in our laboratory, has done 





candidate. Future work with the worms expressing cua-1 transcriptional or 
translational reporters under the endogenous promoter as well as hypodermis-specific 
Cu importer RNAi will determine origin of demands for Cu under Cu-limitation, 
which leads to the up-regulation of CUA-1 in hypodermis.  
In addition, if the trafficking of intestinal CUA-1 is dependent on systemic Cu 
status and peripheral tissue Cu-deficiency rather than Cu status in the intestine, use of 
hypodermis-specific Cu importer silencing in worms expressing Pvha-6::CUA- 
1.1::GFP would answer the question. 
 
Examination of hepatic Ctr1 regulation in Cu-overload condition 
It is well established that Ctr1 is inactivated through post-translational down-
regulation (e.g. endocytosis and degradation) in cell culture and mouse models 
(25,26). Interestingly, we found that in Cu-injected mice, Ctr1 is elevated in the liver 
and that Cu is dramatically accumulated in the liver (~5-fold higher) as compared to 
control mice. Given that mRNA levels of Ctr1 in the liver were not altered by Cu-
deficiency or Cu-injection, elevation of hepatic Ctr1 is regulated at post-
transcriptional levels. Therefore, it is possible that Ctr1 in the liver fails to undergo 
endocytosis and degradation as it does in other tissues to sequester and excrete toxic 
levels of Cu, maintain optimal Cu homeostasis, and protect other Cu-susceptible 
tissues. Identifying the specific molecular mechanism for liver-specific Ctr1 
regulation will provide a holistic view of the coordinated changes in Cu homeostasis 
proteins that result from changes in Cu demand and overload, and the constellation of 






Identifying Cu signals that induce elevation of intestinal ATP7A in Cu-deficient 
mice 
A major caveat of these studies is that we have not shown the molecular 
mechanism by which intestinal ATP7A is increased in Cu-deficient mice. As we have 
observed that intestinal ATP7A expression in both Ctr1int/int (low serum Cu) (15), and 
Ctr1hrt/hrt (high serum Cu) (61) mice is post-transcriptionally elevated, we reason that 
Cu itself is not a direct intestinal ATP7A inducer. Instead, a circulating factor from 
plasma likely mediates ATP7A expression in the intestines of these mice. Our current 
hypothesis is that in mammals, tissue Cu levels are not only maintained cell-
autonomously but also by an inter-organ communication network in which a systemic 
signal mediates crosstalk between organs and the intestine regarding Cu status in Cu-
deficient mammals. 
In our recent preliminary studies (unpublished work), we have evaluated 
mRNA profiles of hearts from P10 Ctr1hrt/hrt mice by microarray in triplicate, and 
found that several hundred genes were differentially regulated as compared to 
controls, based on the assumption that heart tissues undergoing severe Cu deficiency 
activate the expression of secreted proteins that directly serve as the signal, or that 
intracellular proteins involved in the biosynthesis of small molecules that act as the 
signal. As a control for transcripts that are elevated due to general cardiac 
hypertrophy and not related to a Cu deficiency-induced hypertrophy, we analyzed the 
available microarray data in heart tissues from transverse aortic constriction (TAC)-





mice, and from heart-specific transferrin receptor 1 (Tfr1) KO mice (Tfr1hrt/hrt). While 
Tfr1hrt/hrt mice display very similar phenotypes to Ctr1hrt/hrt (i.e., mice lacking cardiac 
Tfr1 died at two weeks of age and demonstrated severe cardiac hypertrophy) (158), 
intestinal ATP7A expression of Tfr1hrt/hrt was not increased, indicating ATP7A 
elevation in the intestine of Ctr1hrt/hrt is not due to general cardiac hypertrophy 
(unpublished work). Among 250 genes, which are specifically elevated in Ctr1hrt/hrt 
hearts, 18 genes encoding secreted proteins were tested as primary Cu signal 
candidates by treating HUVEC cells with the purified mammalian recombinant 
proteins. Interestingly, the abundance of endogenous ATP7A protein in HUVEC cells 
was significantly elevated upon the one of Insulin-like Growth Factor (IGF) Binding 
Protein (IGFBP) family proteins treatment (0.5 µg/ml); this was accompanied by a 
concomitant increase in CCS levels, which is an indicator of bioavailable Cu, likely 
due to enhanced Cu efflux via ATP7A (unpublished work). Future studies are 
underway to determine whether this candidate affects the regulation of ATP7A 
























Name Background Transgene 
BK014 N2 Pvha-6::CUA-1.1::GFP::unc-54 3’ UTR 






BK016 N2 Pvha-6::CUA-1.1::GFP::unc-54 3’ UTR; Pvha-6::mCherry::unc-54 3’ UTR 
BK020 unc-119 (ed3) III Pdpy-7::CUA-1.1::GFP::unc-54 3’ UTR; unc-119 rescue 
BK006 N2 Pcua-1::CUA-1.1::GFP::unc-54 3’ UTR 
BK024 N2 Pvha-6::CUA-1.2::GFP::unc-54 3’ UTR 
 unc-119 (ed3) III Pvha-6::MANS::mCherry::unc-54 3’ UTR; unc-119 rescue 
BK018 N2 Pvha-6::CUA-1::GFP::unc-54 3’ UTR; Pvha-6::MANS::mCherry::unc-54 3’ UTR; 
WM27 rde-1(ne219) V - 
VP303 rde-1(ne219) V Pnhx-2::RDE-1; rol-6 marker 
WM118 rde-1(ne300) V Pmyo-3::HA::RDE-1; rol-6 marker 





















Purpose Name Sequence 
cua-1(ok904) 
genotyping Cua-1_gt_fwd CCAGCTAACCACAATTGTTTTCG 
 Cua-1_gt_rev CGAATCCTTCTCGTCGTCATTTTC 
C. elegans  
RT-qPCR ceCua-1_fwd TGGCACAATCACCGAAGGAC 
 ceCua-1_rev CAATCGGATGCTCCGACAAA 
 ceGpd-2_fwd TGCTCACGAGGGAGACTAC 









Purpose Name Sequence 
Mouse Ctr1 
genotyping Ctr1_gt_fwd AATGTCCTGGTGCGTCTGAAA 
 Ctr1_gt_rev1 GCAGTAGATAAAAGCCAAGGC 
 Ctr1_gt_rev2 AAAAACCACTATTCAGAGACTG 
Mouse 
RT-qPCR mAtp7a_fwd ATGGAGCCAAGTGTGGATG 
 mAtp7a_rev CCAAGGCAGAGTCAGTGGAG 
 mGapdh_fwd ATGGTGAAGGTCGGTGTGAA 
 mGapdh_rev AGTGGAGTCATACTGGAACA 
 mMT1_fwd CACTTGCACCAGCTCCTG 
 mMT1_rev GAAGACGCTGGGTTGGTC 
 mMT2_fwd CAAACCGATCTCTCGTCGAT 
 mMT2_rev AGGAGCAGCAGCTTTTCTTG 
 mCtr1_fwd GGGCTTACCCTGTGAAGACTTTT 
 mCtr1_rev AATGTTGTCGTCCGTGTGGT 
Rat cells 
RT-qPCR rAtp7a_fwd TGAACAGTCATCACCTTCATCGTC 
 rAtp7a_rev TGCATCTTGTTGGACTCCTGAAAG 
 r18s rRNA_fwd GCAATTATTCCCCATGAACG 





Appendix IV. Intestinal CUA-1 distribution is regulated by Cu status in the 
body. Transgenic animals [Pvha-6::CUA-1.1::GFP::unc-54 3’UTR] were injected 
with M9 buffer containing either histidine alone or histidine with CuCl2. (see 
Materials and Methods for details). Arrowheads indicate punctate of CUA-1.1::GFP. 
Scale bar, 20 µm. 
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